Hertfordshire and West Essex ICB
Prescribing, Policies and Pathways
Prescribing, Policies and Pathways
The last day of operation for Hertfordshire and West Essex ICB was 31 March 2026. The information on this website has not been updated since 31 March 2026. The legacy policies, prescribing recommendations and pathways can be accessed on this website. Find out more
or
| Medicine / Guideline | Indication | RAG rating | Document type | Place |
|---|---|---|---|---|
| A frequently asked questions document - NHS Shared care and specialist guided prescribing service specification | Shared Care | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Abaloparatide | Osteoporosis after menopause | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Abatacept | Psoriatic arthritis | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Abatacept | Rheumatoid arthritis - severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Abdomen and Pelvis CT to rule out Pancreatic Cancer | n/a | Decision document | South and West Hertfordshire | |
| Abdominal Hernia | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Abdominoplasty or Apronectomy Surgery Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
| Abdominoplasty or Apronectomy Surgery | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Abrocitinib | Atopic dermatitis - moderate severe | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Acamprosate | Alcohol misuse | Amber initiation | Prescribing guideline | East and North Hertfordshire, South and West Hertfordshire |
| Acamprosate | Alcohol misuse | n/a | Patient information | West Essex |
| Acamprosate | Alcohol misuse | n/a | Patient information | East and North Hertfordshire, South and West Hertfordshire |
| Acamprosate | Alcohol misuse | Amber initiation | Prescribing guideline | West Essex |
| Acarizax (12 SQ-HDM SLIT) | Allergic asthma caused by house dust mites | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Acarizax (12 SQ-HDM SLIT) | Allergic rhinitis caused by house dust mites | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Access To Mental Health Services Guidance | n/a | Decision document | East and North Hertfordshire, South and West Hertfordshire, West Essex | |
| Acenocoumarol | Treatment and prevention of thromboembolic diseases. | Amber initiation | Decision document | Hertfordshire and West Essex ICB |
| Acetylcholinesterase (AChE) inhibitor | Alzheimer's disease dementia | Amber protocol | Shared care protocol | West Essex |
| Acetylcholinesterase (AChE) inhibitor | Alzheimer's disease dementia | Amber initiation | Prescribing support document | East and North Hertfordshire, South and West Hertfordshire |
| Acetylcysteine 600mg capsules | Mucolytic | Double Red | Decision document | Hertfordshire and West Essex ICB |
| Acetylcysteine 600mg effervescent tablets [special] | Mucolytic | Double Red | Decision document | Hertfordshire and West Essex ICB |
| Acetylcysteine 600mg S/F effervescent tablets | Mucolytic | Green | Decision document | Hertfordshire and West Essex ICB |
| Acetylcysteine 600mg tablets | Mucolytic | Double Red | Decision document | Hertfordshire and West Essex ICB |
| Acitretin | Psoriasis, ichthyosis, Darier's disease | Red | Decision document | Hertfordshire and West Essex ICB |
| Acne vulgaris | Acne vulgaris | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Acromioclavicular Joint (ACJ) | n/a | Clinical pathways | South and West Hertfordshire | |
| Actinic keratosis | Actinic keratosis | n/a | Prescribing pathway | Hertfordshire and West Essex ICB |
| Acute and Chronic Otitis Media/Glue Ear and Indications for Grommets | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Acute trial of rimegepant for treatment of migraine - patient questionnaire | Migraine - treating | Green | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Adalimumab | Crohn's disease - moderate to severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Adalimumab | Ulcerative colitis - moderate severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Adalimumab | Psoriasis - moderate severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Adalimumab | Psoriatic arthritis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Adalimumab | Axial spondyloarthritis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Adalimumab | Uveitis - non-infectious (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Adalimumab | Rheumatoid arthritis - moderate | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Adalimumab | Rheumatoid arthritis - severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Adenoidectomy and Tonsillectomy and Grommets Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
| ADHD | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB | |
| Adult ONS & care homes - Position statement | Nutrition support - Malnutrition | n/a | Position statement | Hertfordshire and West Essex ICB |
| Adult ONS & end of life - Position statement | Nutrition support - End of life | n/a | Position statement | Hertfordshire and West Essex ICB |
| Adult ONS in primary care - Quick guide | Nutrition support - Malnutrition | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Adult ONS reviews - Audit supporting guidance | Nutrition support - Malnutrition | n/a | Prescribing support document | Hertfordshire and West Essex ICB |
| Adult ONS reviews - Audit tool | Nutrition support - Malnutrition | n/a | Prescribing support document | Hertfordshire and West Essex ICB |
| Adult ONS reviews - ECF Q&As | Nutrition support - Malnutrition | n/a | Prescribing support document | Hertfordshire and West Essex ICB |
| Adult ONS reviews - SMRs & polypharmacy supporting guidance | Nutrition support - Malnutrition | n/a | Prescribing support document | Hertfordshire and West Essex ICB |
| Adult ONS, dessert style - Position statement | Nutrition support - Malnutrition | Double Red | Position statement | Hertfordshire and West Essex ICB |
| Aflibercept 2mg | Wet AMD | Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Aflibercept 2mg biosimilar | Choroidal neovascularisation (CNV) assoictaed with pathological myopia | Red | Decision document | Hertfordshire and West Essex ICB |
| Aflibercept 2mg biosimilar | Diabetic macular oedema | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Aflibercept 2mg biosimilar | Macular oedema secondary to retinal vein occlusion (branch RVO or central RVO) | Red | Decision document | Hertfordshire and West Essex ICB |
| Aflibercept 8mg | Diabetic macular oedema | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Aflibercept 8mg | wet AMD | Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Agomelatine | Major depressive episodes | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Alcohol Related | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Alemtuzumab | Highly active relapsing remitting multiple sclerosis (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Alendronic acid | Osteoporosis | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Alimemazine | All indications, execluding sedation in paediatrics prior to diagnostic scans | Red | n/a | Hertfordshire and West Essex ICB |
| Alimemazine switch patient letter | Allergy | Double Red | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Alirocumab | Primary hypercholesterolaemia and mixed dyslipidaemia | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Aliskiren | Hypertension | Double Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Alitretinoin | Eczema - hand severe | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Allergic rhinitis pathway | Allergic rhinitis | Green | Prescribing pathway | Hertfordshire and West Essex ICB |
| Allopurinol | Gout 1st line | Green | n/a | Hertfordshire and West Essex ICB |
| Alteplase | Acute ischaemic stroke | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Alternatives To Admission | East and North Hertfordshire | n/a | Clinical pathways | East and North Hertfordshire | |
| Alternatives To Admission | West Essex | n/a | Clinical policy | West Essex | |
| Alternatives To Admission| South West Hertfordshire | n/a | Clinical pathways | South and West Hertfordshire | |
| Amantadine | Parkinson's disease | Amber initiation | n/a | Hertfordshire and West Essex ICB |
| Ambrisentan | Pulmonary arterial hypertension (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Amifampridine | Lambert-Eaton myasthenic syndrome (NHSE) | Double Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Amikacin | Cystic fibrosis (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Amiodarone | Arrythmia | Amber protocol | Shared care protocol | Hertfordshire and West Essex ICB |
| Amiodarone Review Pathway | Arrythmia | Amber protocol | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Amitriptyline | Irritable bowel syndrome (IBS) 2nd line unlicensed | Green | n/a | Hertfordshire and West Essex ICB |
| Anagrelide | Reduction of elevated platelet counts | Red | n/a | Hertfordshire and West Essex ICB |
| Anal fissure | Anal fissure | n/a | Prescribing pathway | Hertfordshire and West Essex ICB |
| Anaphylaxis Auto Adrenaline Injector | Anaphylaxis | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Anastrozole | Familial breast cancer | n/a | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Andexanet alfa | Reversal of anticoagulation for gastrointestinal tract bleed | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Andexanet alfa | Reversing anticoagulation for intracranial haemorrhage | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Anti-platelet Therapy in Suspected TIA | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Antibiotic toolkit TARGET | Antimicrobial stewardship | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Anticholinergic burden (ACB) | Structured medication review Eclipse Live | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Anticholinergic burden (ACB) | Structured medication review Hints and tips | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Antihistamine | Seasonal allergic rhinitis - OTC | n/a | Position statement | Hertfordshire and West Essex ICB |
| Antimicrobial Q&A ECF 2025-26 | Antibiotics - ECF FAQs | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Antipsychotic depot injections | Schizophrenia | Red | n/a | Hertfordshire and West Essex ICB |
| Apomorphine | Parkinson's disease | Red | Decision document | Hertfordshire and West Essex ICB |
| Apremilast | Psoriasis - moderate severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Apremilast | Psoriatic arthritis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Areas of Focus for 2026/27 ECF Target - Summary Document | Guidance - ECF 26/27 | n/a | Primary Care prescribing resource | East and North Hertfordshire, South and West Hertfordshire |
| Aripiprazole | Moderate to severe manic episodes in adolescents with bipolar I disorder | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Aripiprazole oral solution SF to orodispersible tablets Patient letter | Licensed Indications | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Armour thyroid | Hypothyroidism | Double Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Arrhythmia | n/a | Clinical pathways | South and West Hertfordshire | |
| Arthroscopic Sub-acromial Decompression | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Aspirin dipyridamole clopidogrel | Occlusive vascular events prevention | n/a | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Asthma | Inhaled corticosteroids (ICS) choices | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Asthma | MART - Asthma Management in over 12 years | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Asthma | Adults 18 years and over | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Asthma | SABA Q&A ECF 25-26 | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Asthma | Children 5 to 19 years | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Asthma | Step down guidance | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Atogepant | Migraine - chronic | Amber initiation | Prescribing pathway | Hertfordshire and West Essex ICB |
| Atogepant | Migraine - episodic | Amber initiation | Prescribing pathway | Hertfordshire and West Essex ICB |
| Atogepant | Migraine-prevention | Amber initiation | Prescribing support document | Hertfordshire and West Essex ICB |
| Atomoxetine | Attention deficit hyperactivity disorder (ADHD) | Amber protocol | Shared care protocol | East and North Hertfordshire, South and West Hertfordshire |
| Atomoxetine | Attention deficit hyperactivity disorder (ADHD) | Amber protocol | Shared care protocol | West Essex |
| Atrial Fibrillation (AF) | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Attention deficit hyperactivity disorder (ADHD) | ADHD shared care protocol | Amber protocol | Shared care protocol | West Essex |
| Attention deficit hyperactivity disorder (ADHD) | ADHD shared care protocol children and young people (methylphenidate, lisdexamfetamine, dexamfetamine, atomoxetine or guanfacine) | Amber protocol | Shared care protocol | West Essex |
| Attention deficit hyperactivity disorder (ADHD) | ADHD shared care protocol - children, young people and adults | Amber protocol | Shared care protocol | East and North Hertfordshire, South and West Hertfordshire |
| Avatrombopag | Primary chronic immune thrombocytopenia | Red | Decision document | Hertfordshire and West Essex ICB |
| Avatrombopag | Thrombocytopenia in chronic liver disease | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Aveeno switch patient letter | Emollient | Double Red | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Axial Spondyloarthritis | Axial Spondyloarthritis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Azathioprine / mercaptopurine | Multisystem autoimmune disease | Amber protocol | Shared care protocol | West Essex |
| Azathioprine / mercaptopurine | Multisystem autoimmune disease | Amber protocol | Shared care protocol | East and North Hertfordshire, South and West Hertfordshire |
| Azithromycin | COPD | Amber initiation | Prescribing support document | Hertfordshire and West Essex ICB |
| Azithromycin in adults with COPD | Azithromycin in adults with COPD - prophylactic | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Aztreonam lysine | Cystic fibrosis chronic pseudomonas aeruginosa (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Back Pain | n/a | Clinical pathways | East and North Hertfordshire | |
| Baclofen - oral | Spasticity generalised in adults with cerebral palsy | Green | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Baclofen oral | Spasticity generalised in paediatrics with cerebral palsy | Green | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Bariatric Surgery | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Baricitinib | Rheumatoid arthritis - severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Baricitinib | Alopecia areata | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Baricitinib | Atopic dermatitis - moderate severe | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Bath and shower preparations | Dry and pruritic skin conditions | Double Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Behavioural and Psychological Symptoms of Dementia (BPSD) | Dementia | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Bempedoic acid | Primary hypercholesterolaemia or mixed dyslipidaemia | Green | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Benralizumab | Severe eosinophilic asthma (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Betula verrucosa (Itulazax) | Allergic rhinitis or conjunctivitis caused by tree pollen - moderate to severe | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Bevacizumab (Avastin) | Wet AMD | Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Bevacizumab gamma (Lytenava) | Wet AMD | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Bezlotoxumab | Clostridium difficile | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Bibecfo (ICS - beclometasone / LABA - formoterol) | Asthma | Green | Decision document | Hertfordshire and West Essex ICB |
| Bictegravir | AIDS/ HIV Antiretroviral (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Bile salts malabsorption | Bile salts malabsorption | Amber initiation | Decision document | Hertfordshire and West Essex ICB |
| Bimekizumab | Axial Spondyloarthritis | Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Bimekizumab | Psoriatic arthritis | Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Bimekizumab | Psoriasis - moderate severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Biologic and Biosimilar Medicines | Where indicated | n/a | Patient information | Hertfordshire and West Essex ICB |
| Biological Mesh | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Biosimilar insulins (Semglee and Trurapi) | Diabetes | Amber initiation | Decision document | Hertfordshire and West Essex ICB |
| Bisphosphonates | Osteoporosis | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Bladder-Renal Cancer | Suspected | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Blepharitis | Blepharitis | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Blepharoplasty and Brow Lift | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Blepharoplasty and Brow Lift Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
| Blood glucose and ketone meters, test strips and lancets | Diabetes | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Blood glucose meters, test strips and lancets | Type 2 diabetes | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Blood glucose test strips and lancets discontinuation letter | Type 2 diabetes | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Blood glucose test strips and lancets quantity calculator | Diabetes | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Bobath Therapy | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Body Contouring | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Body Contouring Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
| Bosentan | Digital ulcers and pulmonary arterial hypertension (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Botulinum neurotoxin type A | Sialorrhoea | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Botulinum toxin type A | Focal spasticity, Hemi-facial spasm, Blepharospasm, Cervical dystonia, Frey’s syndrome, Chronic anal fissure, Dysphagia, Hirschsprung’s disease, Overactive bladder,Masseteric hypertrophy and temporomandibular disorders | Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| BPSD deprescribing infographic for Prescribers | Care homes | n/a | Prescribing support document | Hertfordshire and West Essex ICB |
| BPSD short guide for Care practitioners | Care homes | n/a | Prescribing support document | Hertfordshire and West Essex ICB |
| Brain and Central Nervous System Cancers | n/a | Clinical pathways | East and North Hertfordshire | |
| Brain MRI for the exclusion of Brain and CNS Cancer | n/a | n/a | South and West Hertfordshire | |
| Breast Cancer - Suspected (Adults >16 years) | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Breast Prosthesis Removal | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Breast Prosthesis Removal Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
| Breast Reduction Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
| Breast Reduction Surgery | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Breast Screening Service | n/a | Patient information | Hertfordshire and West Essex ICB | |
| Breast Surgery (Reconstruction) | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Breast Surgery Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
| Breathlessness | Non-Acute | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Brivaracetam | Epilepsy | Amber initiation | Decision document | Hertfordshire and West Essex ICB |
| Brodalumab | Psoriasis - moderate severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Brolucizumab | Diabetic macular oedema | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Brolucizumab | Wet AMD | Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Bronchiectasis | Bronchiectasis - acute exacerbation of (non-cystic fibrosis) | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Bronchiectasis in Adults | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Budesonide - rectal (Budenofalk) | Ulcerative colitis | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Budesonide (Jorveza) | Inducing remission of eosinophilic oesophagitis | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Budesonide 9mg oral preparations | Crohn's disease, ulcerative colitis or microscopic colitis | Red | n/a | Hertfordshire and West Essex ICB |
| Budesonide targeted release (Kinpeygo) | Primary IgA nephropathy | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Bunions | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Buprenorphine oral lyophilisate | Opioid drug dependence | Double Red | Decision document | Hertfordshire and West Essex ICB |
| Cabotegravir | Preventing HIV-1 | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Calcium & vitamin D | Osteoporosis | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Calcium acetate | Hyperphosphatemia in adult patients with chronic kidney disease | Amber initiation | Decision document | Hertfordshire and West Essex ICB |
| Canagliflozin | Chronic kidney disease | n/a | Prescribing pathway | Hertfordshire and West Essex ICB |
| Candidiasis | Candidiasis - oral | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Candidiasis | Candidiasis - vaginal | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Cangrelor | Reduction of atherothrombotic events in PCI | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Cannabidiol (Epidiyolex®) | Tertiary care indication (NHSE) Suitable for shared care between tertiary and secondary care providers. Adjunctive treatment with clobazam for treating seizures associated with Dravet syndrome and Lennox-Gastaut syndrome (LGS) | Red | Decision document | Hertfordshire and West Essex ICB |
| Cannabis-based medicinal preparations | Intractable nausea & vomiting, chronic pain, spasticity and severe treatment-resistant epilepsy | Red | Position statement | Hertfordshire and West Essex ICB |
| Carbamazepine | Epilepsy | Green | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Carbimazole 10mg tablets dose optimisation switch patient letter | Hyperthyroidism | Green | Patient information | Hertfordshire and West Essex ICB |
| Carbimazole 15mg tablets dose optimisation switch patient letter | Hyperthyroidism | Green | Patient information | Hertfordshire and West Essex ICB |
| Carbocisteine 250mg/5ml oral solution | Mucolytic | Green | Decision document | Hertfordshire and West Essex ICB |
| Carbocisteine 250mg/5ml oral solution S/F | Mucolytic | Double Red | Decision document | Hertfordshire and West Essex ICB |
| Carbocisteine 375mg capsules | Mucolytic | Green | Decision document | Hertfordshire and West Essex ICB |
| Carbocisteine 750mg capsules | Mucolytic | Double Red | Decision document | Hertfordshire and West Essex ICB |
| Carbocisteine 750mg capsules dose optimisation switch patient letter | Green | Patient information | Hertfordshire and West Essex ICB | |
| Carbocisteine 750mg/10ml oral sachets S/F | Mucolytic | Double Red | Decision document | Hertfordshire and West Essex ICB |
| Carbocisteine 750mg/10ml oral solution S/F | Mucolytic | Double Red | Decision document | Hertfordshire and West Essex ICB |
| Care home malnutrition management pathway | Nutrition support - Malnutrition | n/a | Clinical pathways | Hertfordshire and West Essex ICB |
| Care Home Newsletter | Care homes | n/a | Prescribing support document | Hertfordshire and West Essex ICB |
| Care homes - Fortifying food | Nutrition support - Malnutrition | n/a | Patient information | Hertfordshire and West Essex ICB |
| Care homes - Medication pots poster | Medication Administration | n/a | Prescribing support document | Hertfordshire and West Essex ICB |
| Care homes & ONS - Relatives and friends information | Nutrition support - Malnutrition | n/a | Patient information | Hertfordshire and West Essex ICB |
| Care Planning | n/a | Patient information | Hertfordshire and West Essex ICB | |
| Carpal Tunnel - Dupuytren's - Trigger Finger Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
| Carpal Tunnel Syndrome | n/a | Clinical pathways | South and West Hertfordshire | |
| Carpal Tunnel Syndrome release | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Carpometacarpal Joint Osteoarthritis | n/a | Clinical pathways | South and West Hertfordshire | |
| Casirivimab plus imdevimab | COVID-19 | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Cataract Surgery | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Catheter formulary | Continence | n/a | Prescribing guideline | East and North Hertfordshire, South and West Hertfordshire |
| Catheter formulary | Continence | n/a | Prescribing guideline | West Essex |
| Catheter Prescription Ordering Form | Continence | n/a | Primary Care prescribing resource | East and North Hertfordshire, South and West Hertfordshire |
| Cefiderocol | Drug-resistant gram-negative bacterial infections severe (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Ceftazidime with avibactam | Drug-resistant gram-negative bacterial infections severe (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Cellulitis and erysipelas | Cellulitis and erysipelas | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Cenobamate | Epilepsy | Amber initiation | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Certoliziumab | Psoriasis - moderate severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Certolizumab | Psoriatic arthritis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Certolizumab | Rheumatoid arthritis - severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Certolizumab | Axial spondyloarthritis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Cervical Screening Decision for Adults with Learning Difficulties | n/a | Clinical pathways | South and West Hertfordshire | |
| Cervical Spine and Pain | n/a | n/a | South and West Hertfordshire | |
| Chalazia (meibomian cysts) removal | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Chalazia Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
| Chest Pain | n/a | Clinical pathways | South and West Hertfordshire | |
| Child Sexual Exploitation | n/a | Patient information | Hertfordshire and West Essex ICB | |
| Children's Cancer | n/a | Patient information | Hertfordshire and West Essex ICB | |
| Chlamydia trachomatis / urethritis | Chlamydia trachomatis / urethritis | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Chlorambucil | Cancer indications | Red | n/a | Hertfordshire and West Essex ICB |
| Chlormethine gel | Mycosis fungoides-type cutaneous T-cell lymphoma (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Cholecystectomy | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Choroidal neovascularisation (CNV) associated with pathological myopia | Choroidal neovascularisation (CNV) assoictaed with pathological myopia | Red | Decision document | Hertfordshire and West Essex ICB |
| Chronic and Acute Sinusitis | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Chronic Fatigue Syndrome/Myalgic Encephalitis (CFS & ME) Inpatient Treatment | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Chronic Kidney Disease - Treatment Pathway | Chronic kidney disease | n/a | Prescribing pathway | Hertfordshire and West Essex ICB |
| Chronic Pelvic Pain Endometriosis | n/a | Clinical pathways | South and West Hertfordshire | |
| Ciclosporin eye drops | Dry eye disease that has not improved despite treatment with artificial tears | Amber initiation | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Cilostazol | Intermittent claudication in people with peripheral arterial disease | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Cinacalcet | Secondary Hyperparathyroidism in Adults with End Stage Kidney Disease Requiring Renal Replacement Therapy | Amber protocol | Shared care protocol | Hertfordshire and West Essex ICB |
| Ciprofibrate | Hypercholesterolaemia | Double Red | n/a | Hertfordshire and West Essex ICB |
| Cladribine | Relapsing–remitting multiple sclerosis (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Clascoterone | Acne Vulgaris | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Clinical brand prescribing guidance | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB | |
| Clomipramine | Narcolepsy (tertiary centre only) some have agreed amber protocol | Amber initiation | n/a | Hertfordshire and West Essex ICB |
| Clonazepam | Epilepsy | Amber initiation | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Clonidine | Attention deficit hyperactivity disorder (ADHD) | Red | Decision document | Hertfordshire and West Essex ICB |
| Clostridioides difficile infection | Clostridioides difficile infection | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Clozapine | Schizophrenia | Red | n/a | Hertfordshire and West Essex ICB |
| Co-beneldopa | Parkinson's disease | Amber initiation | n/a | Hertfordshire and West Essex ICB |
| Co-careldopa | Parkinson's disease | Amber initiation | n/a | Hertfordshire and West Essex ICB |
| Co-careldopa (Carbidopa/levodopa) intestinal gel | Parkinson's disease (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Co-careldopa Intestinal Gel (Duodopa) | Parkinson's Disease (NHSE tertiary centre only) | Red | n/a | Hertfordshire and West Essex ICB |
| Co-danthramer | Constipation - restricted to constipation in terminally ill patients of all ages | Green | Decision document | Hertfordshire and West Essex ICB |
| Co-proxamol | Pain | Double Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Co-proxamol | Pain | n/a | Patient information | Hertfordshire and West Essex ICB |
| Colchicine | Gout 2nd line | Green | n/a | Hertfordshire and West Essex ICB |
| Cold sores | Cold sores | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Colesevelam | Bile acid sequestrants for prevention of CVD | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Colesevelam 2nd line | Diarrhoea associated with bile acid malabsorption | Amber initiation | n/a | Hertfordshire and West Essex ICB |
| Colestyramine | Bile acid sequestrants for prevention of CVD | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Colestyramine 1st line | Diarrhoea associated with bile acid malabsorption | Amber initiation | n/a | Hertfordshire and West Essex ICB |
| Colistimethate sodium (Colobreathe) | Cystic fibrosis (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Combodart ((tamsulosin/ dutasteride) | Benign prostatic hyperplasia | Double Red | n/a | Hertfordshire and West Essex ICB |
| Community Breast Pain | n/a | Clinical pathways | East and North Hertfordshire | |
| Community LRTI Pneumonia Intravenous Antibiotic pathway for Housebound Care Home patients Pathway | n/a | Clinical pathways | East and North Hertfordshire | |
| Complementary & Alternative Therapies | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Complex Case Management, Locality MDT, and Frailty Clinics | n/a | n/a | South and West Hertfordshire | |
| Compression formulary - ICS wide | Surgery | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Continuous Glucose Monitoring - Adults - Initiation Specialist to GP letter | Diabetes | Amber initiation | Prescribing guideline | Hertfordshire and West Essex ICB |
| Continuous Glucose Monitoring - Dexcom ONE to ONE+ Switch Letter to Patient | Diabetes | Amber initiation | Prescribing guideline | Hertfordshire and West Essex ICB |
| Continuous Glucose Monitoring - Discontinuation Specialist to GP letter | Diabetes | Amber initiation | Prescribing guideline | Hertfordshire and West Essex ICB |
| Continuous Glucose Monitoring - FSL2 to FSL2 Plus Sensor Switch Letter to Patient | Diabetes | Amber initiation | Prescribing guideline | Hertfordshire and West Essex ICB |
| Continuous Glucose Monitoring - FSL3 to FSL3 Plus Sensor Switch Letter to Patient | Diabetes | Amber initiation | Prescribing guideline | Hertfordshire and West Essex ICB |
| Continuous Glucose Monitoring - Paediatric - Initiation Specialist to GP letter | Diabetes | Amber initiation | Prescribing guideline | Hertfordshire and West Essex ICB |
| Continuous Glucose Monitoring for Adults: Position Statement | n/a | Position statement | Hertfordshire and West Essex ICB | |
| Continuous Glucose Monitoring for patients with Type1 and Type 2 Diabetes | n/a | Patient information | Hertfordshire and West Essex ICB | |
| Continuous Glucose Monitoring Paediatrics: Position Statement | n/a | Position statement | Hertfordshire and West Essex ICB | |
| Contraception | Contraception | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| COPD | COPD - acute exacerbation of | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| COPD | COPD | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| COPD Pathway | n/a | Clinical pathways | East and North Hertfordshire | |
| COPD treatment guidelines | COPD | n/a | Decision document | Hertfordshire and West Essex ICB |
| Correction of Congenital Ear Deformity, Pinnaplasty – Otoplasty | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Correction of Congenital Ear Deformity/Pinnaplasty – Otoplasty Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
| Correction of Privately Funded Treatments | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Cosmetic Breast Surgery | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Cosmetic Breast Surgery Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
| Cosmetic interventions for individuals with Gender Dysphoria or post Gender Reassignment surgery | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Cosmetic Procedures | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Cosopt eye drops to generic-switch-letter | Glaucoma, raised IOP | n/a | Patient information | Hertfordshire and West Essex ICB |
| Cough | Cough - acute | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Cough in Adults | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| COVID Virtual Ward | n/a | Patient information | East and North Hertfordshire | |
| COVID-19 Oximetry at Home | n/a | Patient information | East and North Hertfordshire | |
| COVID-19 Respiratory Disease Update | n/a | Patient information | Hertfordshire and West Essex ICB | |
| COVID-19 treatments: Information for care homes | COVID 19 | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| COVID-19 treatments: Information for clinicians | COVID-19 | n/a | Prescribing pathway | Hertfordshire and West Essex ICB |
| COVID-19 treatments: Information for community pharmacists | COVID 19 | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Crohn's disease | Crohn's disease - moderate to severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Croup | Paediatrics | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| CT Request and 2WW Non-Specific Symptoms Referral Pathway | n/a | Clinical pathways | South and West Hertfordshire | |
| CYP Eating Disorders and Emotional Distress | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Cystistat | Chronic inflammation or infection of the bladder | Double Red | Decision document | Hertfordshire and West Essex ICB |
| Cytisine (cytisinicline) | Smoking cessation | Red | n/a | Hertfordshire and West Essex ICB |
| Dalteparin | Anticoagulation | Red | n/a | Hertfordshire and West Essex ICB |
| Dapagliflozin | Diabetes type 1 | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Dapagliflozin | Chronic Heart Failure | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Dapagliflozin | Chronic kidney disease | n/a | Prescribing pathway | Hertfordshire and West Essex ICB |
| Dapagliflozin patient friendly information resource | n/a | Patient information | Hertfordshire and West Essex ICB | |
| Dapagliflozin Switch Guidance | n/a | Prescribing guideline | Hertfordshire and West Essex ICB | |
| Dapagliflozin switch patient letter | Diabetes | n/a | Prescribing support document | Hertfordshire and West Essex ICB |
| Dapoxetine | Premature ejaculation | Double Red | Decision document | Hertfordshire and West Essex ICB |
| Dapsone | Licensed Indications | Amber protocol | Shared care protocol | Hertfordshire and West Essex ICB |
| Darbepoetin | Anaemia with chemotherapy (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Darbepoetin | Anaemia with chronic kidney disease | Red | Decision document | Hertfordshire and West Essex ICB |
| Daridorexant | Long-term insomnia | Green | Prescribing support document | Hertfordshire and West Essex ICB |
| Daridorexant | Insomnia | Green | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Daridorexant | Long-term insomnia | Green | Patient information | Hertfordshire and West Essex ICB |
| Darunavir | AIDS/ HIV Antiretroviral (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Darvadstrocel | Complex perianal fistulas in Crohn’s disease | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Dasatinib | Cancer (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| De Quervains Pathway | n/a | Clinical pathways | South and West Hertfordshire | |
| Deep Vein Thrombosis (DVT) | n/a | Clinical pathways | East and North Hertfordshire | |
| Deferasirox | Blood transfusion related iron overload in patients with myelodysplastic syndrome | Double Red | Decision document | Hertfordshire and West Essex ICB |
| Deferiprone | Blood transfusion related iron overload in patients with myelodysplastic syndrome | Double Red | Decision document | Hertfordshire and West Essex ICB |
| Delgocitinib | Chronic Hand Eczema | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Delta-9-tetrahydrocannabinol [THC] and cannabidiol [CBD] spray (Sativex®) | Spasticity in multiple sclerosis (MS) | Red | Decision document | Hertfordshire and West Essex ICB |
| Dementia | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Denosumab | Osteoporosis | Amber initiation | Prescribing guideline | Hertfordshire and West Essex ICB |
| Denosumab 60mg biosimilar: Patient Information | Osteoporosis | Amber initiation | Patient information | Hertfordshire and West Essex ICB |
| Denosumab letter template | Osteoporosis | Amber initiation | Prescribing guideline | Hertfordshire and West Essex ICB |
| Denosumab prescribing support document | Osteoporosis | Amber initiation | Prescribing support document | Hertfordshire and West Essex ICB |
| Denosumab Xgeva® | Prevention of skeletal-related events (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Dental abscess | Dental abscess | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Dependence forming medicine | Pain - ECF FAQs | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Deprescribing in Adults with Type 2 Diabetes | Type 2 diabetes | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Depression | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Dermatology / Skin Lesions / Skin Health for Adults over 16 years old | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Dermatophyte infection | Dermatophyte infection: skin | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Dermatophyte infection | Dermatophyte infection: nail | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Desferrioxamine | Blood transfusion related iron overload in patients with myelodysplastic syndrome | Double Red | Decision document | Hertfordshire and West Essex ICB |
| Deucravacitinib | Psoriasis - moderate severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Dexamethasone intravitral implant | Macular oedema secondary to retinal vein occlusion (branch RVO or central RVO) | Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Dexamethasone intravitreal implant | Uveitis - non-infectious | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Dexamethasone intravitreal implant | Diabetic macular oedema | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Dexamfetamine | Attention deficit hyperactivity disorder (ADHD) | Amber protocol | Shared care protocol | East and North Hertfordshire, South and West Hertfordshire |
| Dexamfetamine | Attention deficit hyperactivity disorder (ADHD) | Amber protocol | Shared care protocol | West Essex |
| Dexamfetamine | Narcolepsy (tertiary centre only) some have agreed amber protocol | Amber initiation | n/a | Hertfordshire and West Essex ICB |
| Diabetes | n/a | Clinical pathways | South and West Hertfordshire | |
| Diabetes - Structured Education for Type 2 | n/a | Patient information | East and North Hertfordshire | |
| Diabetes type 1 | What to do when you are ill | n/a | Patient information | Hertfordshire and West Essex ICB |
| Diabetes type 2 | What to do when you are ill | n/a | Patient information | Hertfordshire and West Essex ICB |
| Diabetes type 2 | Diabetic ketoacidosis (DKA) | n/a | Patient information | Hertfordshire and West Essex ICB |
| Diabetic foot infection | Diabetic foot infection | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Diabetic Macular Oedema | Diabetic Macular Oedema | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Diagnosing Asymptomatic Heart Murmur | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Diarrhoea | Diarrhoea infectious | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Diarrhoea | Diarrhoea - Traveller’s | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Diastasis Recti Repair | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Diastasis Recti Repair Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
| Dibotermin alfa | Promotion of ectopic bone formation | Red | Decision document | Hertfordshire and West Essex ICB |
| Diclofenac sodium 3% gel | Actinic keratosis | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Dicycloverine | Irritable bowel syndrome (IBS) | Double Red | n/a | Hertfordshire and West Essex ICB |
| Dienogest | Endometriosis | Amber initiation | Decision document | Hertfordshire and West Essex ICB |
| Dilatation & curettage for heavy menstrual bleeding | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Diltiazem ointment 3rd line | Anal fissures | Green | n/a | Hertfordshire and West Essex ICB |
| Dimethyl fumarate | Psoriasis - moderate severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Dipeptidyl peptidase-4 inhibitors (Gliptins) | Diabetes type 2 | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Divarication of Recti | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Diverticulitis | Diverticulitis - acute | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Division of Ankyloglossia (Tongue Tie) | n/a | Clinical pathways | Hertfordshire and West Essex ICB, South and West Hertfordshire, West Essex | |
| Division of Ankyloglossia (Tongue Tie) Prior Approval Form | Red | Prior approval form | Hertfordshire and West Essex ICB | |
| DOAC (best value DOAC - 1st line generic apixaban & rivaroxaban) | Treatment of deep vein thrombosis (DVT) or pulmonary embolism (PE) and prevention of recurrent DVT and PE | Amber initiation | n/a | Hertfordshire and West Essex ICB |
| DOAC (best value DOAC - 1st line generic apixaban & rivaroxaban) | VTE prophylaxis following hip and knee surgery | Red | n/a | Hertfordshire and West Essex ICB |
| DOAC (best value DOAC - 1st line generic apixaban & rivaroxaban) | Treatment for non-valvular atrial fibrillation | Green | n/a | Hertfordshire and West Essex ICB |
| DOACs | DOAC patient counselling checklist | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| DOACs | Anticoagulation - Atrial fibrillation (AF) guidance | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Docusate sodium | Constipation | Green | n/a | Hertfordshire and West Essex ICB |
| Dolutegravir | AIDS/ HIV Antiretroviral (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Domperidone | Nausea vomiting in children | Double Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Donepezil | Alzheimer's disease dementia | Amber initiation | Prescribing support document | East and North Hertfordshire, South and West Hertfordshire |
| Donepezil | Alzheimer's disease dementia | Amber protocol | Shared care protocol | West Essex |
| Donepezil Orodispersible tablets to tablets Patient letter | Licensed Indications | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Dornase alfa | Cystic fibrosis (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Dosulepin | Depression | Double Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Dosulepin Patient Information Leaflet | Depression | n/a | Patient information | Hertfordshire and West Essex ICB |
| Dosulepin stopping and switching guidance | Depression | Double Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Doxazosin (prolonged release) | Hypertension, benign prostatic hyperplasia (BPH) | Double Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Doxazosin 8mg to 4mg tablets-switch-letter | Hypertension | n/a | Patient information | Hertfordshire and West Essex ICB |
| Doxazosin Prolonged-Release Patient Information Leaflet | Hypertension, benign prostatic hyperplasia (BPH) | n/a | Patient information | Hertfordshire and West Essex ICB |
| Doxylamine with Pyridoxine (Xonvea®) | Nausea and Vomiting in pregnancy | Red | n/a | Hertfordshire and West Essex ICB |
| Dronedarone - Adults | Arrythmia | Amber protocol | Shared care protocol | Hertfordshire and West Essex ICB |
| Drug Titration and Review for Neuropathic Pain | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Dry Eye Disease | Dry eye disease | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Dry eye lubrication drops & gels – frequently asked questions. | Dry eye disease | n/a | Patient information | Hertfordshire and West Essex ICB |
| Dual GIP with GLP-1 RA or GLP-1 RA with Insulin guidance document | Type 2 Diabetes | Amber initiation | Prescribing guideline | Hertfordshire and West Essex ICB |
| Dual GIP with GLP-1 RA or GLP-1RA comparison document | Type 2 Diabetes | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Dupilumab | Eosinophilic oesophagitis | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Dupilumab | chronic rhinosinusitis with nasal polyps | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Dupilumab | Prurigo Nodularis | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Dupilumab | Atopic dermatitis - moderate severe | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Dupuytren's Contracture - Assessment | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Dupuytren’s contracture release in adults (Surgery and Injections) | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Dysthyroid Eye Disease | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Ear Ache | Adult | n/a | Clinical pathways | South and West Hertfordshire | |
| Ear Infection | Adult | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Ear Wax | Adult and Children | n/a | Clinical pathways | South and West Hertfordshire | |
| Ear Wax Removal - Microsuction - Adults Only | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Eating & drinking at end of life | Nutrition support - End of life | n/a | Patient information | Hertfordshire and West Essex ICB |
| Eating Disorders | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Eating well - Homemade supplements | Nutrition support - Malnutrition | n/a | Patient information | Hertfordshire and West Essex ICB |
| Eating well - Homemade supplements videos | Nutrition support - Malnutrition | n/a | Patient information | Hertfordshire and West Essex ICB |
| Eating well - Quick guide | Nutrition support - Malnutrition | n/a | Patient information | Hertfordshire and West Essex ICB |
| Eating well for small appetites | Nutrition support - Malnutrition | n/a | Patient information | Hertfordshire and West Essex ICB |
| Eating, drinking & ageing well | Healthy eating - Older adults | n/a | Patient information | Hertfordshire and West Essex ICB |
| Eclipse Live | Advice and Guidance FAQs | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Eczema (bacterial infection) | Eczema (bacterial infection) | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Efavirenz | AIDS/ HIV Antiretroviral (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Elbasvir | Hepatitis C (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Elbow Pain | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Electronic Cigarettes and other novel nicotine containing products | Tobacco dependance | Red | Position statement | Hertfordshire and West Essex ICB |
| Elleste Duet | Hormone replacement therapy (HRT) | Green | n/a | Hertfordshire and West Essex ICB |
| Eltrombopag | Thrombocytopenia related to hepatitis C | Red | Decision document | Hertfordshire and West Essex ICB |
| Eltrombopag | Aplastic anaemia | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Eltrombopag ITP | Chronic immune thrombocytopenia | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Emergency Contraception Guideline | Emergency Contraception | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Emollient Guidelines | Topical Use | n/a | Decision document | Hertfordshire and West Essex ICB |
| Emollients | Topical Use | n/a | Patient information | Hertfordshire and West Essex ICB |
| Emollients Patient Information Leaflet for Mild Dry Skin Conditions - Over the Counter (OTC) | Mild Dry Skin Conditions | n/a | Patient information | Hertfordshire and West Essex ICB |
| Empagliflozin | Chronic kidney disease | n/a | Prescribing pathway | Hertfordshire and West Essex ICB |
| Empagliflozin | Chronic Heart Failure | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Emtricitabine | AIDS/ HIV Antiretroviral (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| End of Life (EOL) | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Endometriosis | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Enoxaparin | Anticoagulation | Red | n/a | Hertfordshire and West Essex ICB |
| Entacapone | Parkinson's disease | Amber initiation | n/a | Hertfordshire and West Essex ICB |
| Entecavir | Hepatitis B (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Epididymitis | Epididymitis | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Epidural Injections and Therapeutic Nerve Blocks for Lumbar or Sacral Radiculopathy | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Epidural Injections and Therapeutic Nerve Blocks for Lumbar or Sacral Radiculopathy Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
| Epilepsy, Fits and Seizures | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Epoetin | Anaemia with chronic kidney disease | Red | Decision document | Hertfordshire and West Essex ICB |
| Epoietin | Anaemia with chemotherapy (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Eptinezumab | Migraine - episodic | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Eptinezumab | Migraine - chronic | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Erectile dysfunction guidelines | Erectile dysfunction | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Erenumab | Migraine - chronic | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Erenumab | Migraine - episodic | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Erlotinib | All indications (NHSE) | Red | n/a | Hertfordshire and West Essex ICB |
| Erythropoiesis stimulating agents | Anaemia with chronic kidney disease | Red | Decision document | Hertfordshire and West Essex ICB |
| Esketamine | Depression - major | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Estriol cream patient letter | Vaginal atrophy due to oestrogen deficiency | Green | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Etanercept | Psoriasis - moderate severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Etanercept | Psoriatic arthritis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Etanercept | Rheumatoid arthritis - severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Etanercept | Axial spondyloarthritis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Etanercept | Rheumatoid arthritis - moderate | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Ethambutol | Tuberculosis (NHSE) | Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Ethosuximide | Absence seizures, atypical absence seizures (adjunct) and myoclonic seizures in adults and children. | Amber initiation | Prescribing support document | Hertfordshire and West Essex ICB |
| Ethosuximide capsules | Absence seizures, atypical absence seizures (adjunct) and myoclonic seizures in adults and children. | Amber initiation | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Ethosuximide syrup | Absence seizures, atypical absence seizures (adjunct) and myoclonic seizures in adults and children. | Amber initiation | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Etoposide | Cancer (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Etrasimod | Ulcerative Colitis - moderate to severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Evolocumab | Primary hypercholesterolaemia and mixed dyslipidaemia | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Evorel | Hormone replacement therapy (HRT) Patches are 2nd choice when tablets not suitable | Green | n/a | Hertfordshire and West Essex ICB |
| Evorel conti | Hormone replacement therapy (HRT) Patches are 2nd choice when tablets not suitable | Green | n/a | Hertfordshire and West Essex ICB |
| Exemestane | Familial breast cancer | Amber initiation | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Exercise Protocol for the Management of CHD (Exercise for Cardiac Conditions) | n/a | Clinical pathways | East and North Hertfordshire | |
| Exogen | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Faecal Immunochemical Test (FIT) process pathway for suspected Lower GI Cancer | n/a | Clinical pathways | Hertfordshire and West Essex ICB, South and West Hertfordshire | |
| Faecal Microbiota Transplants | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Falls Pathways | n/a | n/a | Hertfordshire and West Essex ICB | |
| Fampridine | Multiple sclerosis (NHSE) | Double Red | Decision document | Hertfordshire and West Essex ICB |
| Faricimab | Diabetic macular oedema | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Faricimab | Macular oedema secondary to retinal vein occlusion (branch RVO or central RVO) | Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Faricimab | Wet AMD | Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Febuxostat | Gout 2nd line | Green | n/a | Hertfordshire and West Essex ICB |
| Female Sterilisation | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Female Sterilisation Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
| Femoston | Hormone replacement therapy (HRT) | Green | n/a | Hertfordshire and West Essex ICB |
| Femoston conti | Hormone replacement therapy (HRT) | Green | n/a | Hertfordshire and West Essex ICB |
| Fentanyl immediate release (IR) | Pain (except for palliative care) | Double Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Fentanyl Immediate-Release Patient Information Leaflet | Pain (except for palliative care) | n/a | Patient information | Hertfordshire and West Essex ICB |
| Ferric maltol | Iron deficiency | Double Red | n/a | Hertfordshire and West Essex ICB |
| Fertility treatment and referral criteria for tertiary level assisted conception (IVF/IUI) Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
| Fertility treatment and referral criteria for tertiary level assisted conception (IVF/IUI) | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Filgotinib | Rheumatoid arthritis - severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Filgotinib | Ulcerative colitis - moderate severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Filgotinib | Rheumatoid arthritis - moderate | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Filgrastim | Neutropenia (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Finerenone | Chronic kidney disease | Green | Prescribing support document | Hertfordshire and West Essex ICB |
| Fingolimod | Highly active relapsing–remitting multiple sclerosis (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Fitness For Surgery | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Flu vaccine claiming | vaccinations | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Fludrocortisone | Orthostatic Hypotension | Amber initiation | Prescribing support document | Hertfordshire and West Essex ICB |
| Fluocinolone intravitreal implant | Diabetic macular oedema | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Fluocinolone intravitreal implant | Uveitis - non-infectious | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Fluorouracil 0.5% / Salicylic acid 10% cutaneous solution | Actinic keratosis | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Fluoxetine oral solution to dispersible tablets switch Patient letter | Licensed Indications | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Fluticasone furoate 27.5micrograms/dose nasal spray (Avamys®) | Allergic rhinitis 3rd line | Green | Decision document | Hertfordshire and West Essex ICB |
| Fluticasone propionate 50micrograms/dose nasal spray (prescribed as Nasofan® only) | Allergic rhinitis 2nd line | Green | Decision document | Hertfordshire and West Essex ICB |
| Fondaparinux | Thrombosis | Red | n/a | Hertfordshire and West Essex ICB |
| Foot / Lower Leg Wounds, including Ulcers | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Foot & Ankle Pain and Disorders excluding Bunions | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Foot Health for Diabetic Patients | n/a | Patient information | East and North Hertfordshire | |
| Foot Symptoms | Adults Only | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Foreskin Problems - Paraphimosis & Phimosis & Circumcision | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Fostamatinib | Chronic immune thrombocytopenia | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Frailty | Acute, Urgent and Emergency | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Frailty Identification | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Fremanezumab | Migraine - chronic | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Fremanezumab | Migraine - episodic | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Fulvestrant | Locally advanced or metastatic breast cancer | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Functional Electrical Stimulation | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Functional Electrical Stimulation Prior Approval Form | Red | Prior approval form | Hertfordshire and West Essex ICB | |
| Fungal Nail Management | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Gabapentin | Epilepsy | Amber initiation | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Galantamine | Alzheimer's disease dementia | Amber initiation | Decision document | East and North Hertfordshire, South and West Hertfordshire |
| Galantamine | Alzheimer's disease dementia | Amber protocol | Shared care protocol | West Essex |
| Galcanezumab | Migraine - chronic | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Galcanezumab | Migraine - episodic | Red | Prescribing pathway | Hertfordshire and West Essex ICB, East and North Hertfordshire, South and West Hertfordshire, West Essex |
| Galstones | n/a | Clinical pathways | South and West Hertfordshire | |
| Gambling | n/a | n/a | Hertfordshire and West Essex ICB | |
| Gamete Storage | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Gamete Storage PA form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
| Ganglion | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Ganglion Excision | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Ganglion Excision Prior Approval form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
| Gefapixant | Refractory or unexplained chronic cough | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Gemfibrozil | Hypercholesterolaemia | Double Red | n/a | Hertfordshire and West Essex ICB |
| Gender Dysphoria | n/a | n/a | Hertfordshire and West Essex ICB | |
| Generic medicines statement | n/a | Prescribing support document | Hertfordshire and West Essex ICB | |
| Genital herpes | Genital herpes | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Gingivitis | Gingivitis - simple - mucosal ulceration and inflammation | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Gingivitis | Gingivitis - acute necrotising ulcerative | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Glatiramer | Multiple sclerosis (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Glenohumeral Joint (Shoulder Pain) | n/a | Clinical pathways | South and West Hertfordshire | |
| Glucophage SR tablets to generic-switch-letter | Diabetes | n/a | Patient information | Hertfordshire and West Essex ICB |
| Glucosamine and chondroitin | Osteoarthritis | Double Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Glucosamine and Chondroitin Patient Information Leaflet | Osteoarthritis | n/a | Patient information | Hertfordshire and West Essex ICB |
| Gluten Free food - Implementation Support | Coeliac disease | n/a | Prescribing guideline | West Essex |
| Gluten Free food - Patient information | Coeliac disease | n/a | Patient information | South and West Hertfordshire |
| Gluten free food - Prescribing guideline | Coeliac disease | n/a | Prescribing guideline | East and North Hertfordshire |
| Gluten Free food - Prescribing guideline | Coeliac disease | n/a | Prescribing guideline | West Essex |
| Gluten Free food - Prescribing guideline | Coeliac disease | n/a | Prescribing guideline | South and West Hertfordshire |
| Gluten free food - Prescribing guideline exceptions | Coeliac disease | n/a | Prescribing guideline | East and North Hertfordshire |
| Glyceryl trinitrate ointment 2nd line | Anal fissures | Green | n/a | Hertfordshire and West Essex ICB |
| Glycopyrronium bromide | Hyperhidrosis | Double Red | Decision document | Hertfordshire and West Essex ICB |
| Glycopyrronium bromide oral | Hypersalivation - adults | Double Red | n/a | Hertfordshire and West Essex ICB |
| Golimumab | Psoriatic arthritis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Golimumab | Rheumatoid arthritis - severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Golimumab | Axial spondyloarthritis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Golimumab | Ulcerative colitis - moderate severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Gonorrhoea | Gonorrhoea | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Good practice guidance - Anticoagulation | Care homes | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Good practice guidance - Controlled drugs | Care homes | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Good practice guidance - Covert administration | Care homes | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Good practice guidance - Emollients | Care homes | n/a | Prescribing support document | Hertfordshire and West Essex ICB |
| Good practice guidance - Fridge temperature record | Care homes | n/a | Prescribing support document | Hertfordshire and West Essex ICB |
| Good practice guidance - High Risk Drugs | Care homes | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Good practice guidance - Homely remedy and self care | Care homes | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Good practice guidance - Medication allergies and sensitivities | Care homes | n/a | Prescribing support document | Hertfordshire and West Essex ICB |
| Good practice guidance - Medicines and falls management | Care homes | n/a | Prescribing support document | Hertfordshire and West Essex ICB |
| Good practice guidance - Medicines reconciliation and transfer of care | Care homes | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Good practice guidance - Mid-cycle medication changes | Care homes | n/a | Prescribing support document | Hertfordshire and West Essex ICB |
| Good practice guidance - Monthly medicines ordering cycle | Care homes | n/a | Prescribing support document | Hertfordshire and West Essex ICB |
| Good practice guidance - Omitted and delayed medicines | Care homes | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Good practice guidance - Oxygen use in Care homes | Care homes | n/a | Prescribing support document | Hertfordshire and West Essex ICB |
| Good practice guidance - Self-Administration of Medicines | Care homes | n/a | Prescribing support document | Hertfordshire and West Essex ICB |
| Good practice guidance - Template forms | Care homes | n/a | Prescribing support document | Hertfordshire and West Essex ICB |
| Good practice guidance - When Required 'PRN' medicines | Care homes | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Good practice guidance: Maintaining good bowel health and preventing constipation | Care homes | n/a | Prescribing support document | Hertfordshire and West Essex ICB |
| Grazoprevir | Hepatitis C (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Grommet insertion in Adults | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Grommet Insertion In Adults Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
| Grommets for glue ear in children | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Guanfacine | Atttention deficit hyperactivity disorder (ADHD) - in children | Amber protocol | Shared care protocol | East and North Hertfordshire, South and West Hertfordshire |
| Guanfacine | Atttention deficit hyperactivity disorder (ADHD) - in children | Amber protocol | Shared care protocol | West Essex |
| Guidance for Self-monitoring of Blood Glucose (SMBG) for patients with Diabetes Mellitus | Diabetes | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Guidelines on Choice and Selection of Antidepressants for the Management of Depression | Depression | n/a | Prescribing guideline | East and North Hertfordshire, South and West Hertfordshire |
| Guselkumab | Psoriasis - moderate severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Guselkumab | Psoriatic arthritis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Gynaecological Cancers - Suspected | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Haematological Cancer – Suspected | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Haematospermia | n/a | Clinical pathways | South and West Hertfordshire | |
| Haematuria | n/a | Clinical pathways | South and West Hertfordshire | |
| Haemorrhoid Surgery | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Haemorrhoid Surgery Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
| Haemorrhoids | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Hallux Valgus (Bunion) Surgery | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Hallux Valgus (Bunion) Surgery Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
| Hand and Wrist including Dupuytren's, Trigger Finger and Carpal Tunnel | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Head and Neck Cancer - Suspected | n/a | Clinical pathways | East and North Hertfordshire | |
| Headache | n/a | Clinical pathways | Hertfordshire and West Essex ICB, South and West Hertfordshire | |
| Hearing Loss/Deafness | Adult | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Heart Failure | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Heart Valve Disease | n/a | Clinical pathways | South and West Hertfordshire | |
| Heartburn and Indigestion PIL | Heartburn and Indigestion | n/a | Patient information | Hertfordshire and West Essex ICB |
| Heavy Menstrual Bleeding (HMB) - Primary Care | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Helicobacter pylori | Helicobacter pylori | Green | Decision document | Hertfordshire and West Essex ICB |
| Herbal treatments and other natural products | All indication | Double Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Herbal Treatments Patient Information Leaflet | All indications | n/a | Patient information | Hertfordshire and West Essex ICB |
| Herpes zoster / shingles | Herpes zoster / shingles | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Hertfordshire Adult Anticipatory Medication Administration Record v5 | Palliative Care | n/a | Primary Care prescribing resource | East and North Hertfordshire, South and West Hertfordshire |
| Hertfordshire Adult Anticipatory Medication and Syringe Pump Chart Training | Anticipatory Prescribing Chart Training | n/a | Primary Care prescribing resource | East and North Hertfordshire, South and West Hertfordshire |
| Hertfordshire Adult Anticipatory Medication and Syringe Pump Chart v5 | Palliative Care | Green | Primary Care prescribing resource | East and North Hertfordshire, South and West Hertfordshire |
| Hertfordshire Adult Anticipatory Medication Stock Control Forms v5 | Palliative Care | n/a | Primary Care prescribing resource | East and North Hertfordshire, South and West Hertfordshire |
| High Dose Opioid Prescribing Top Tips Checklist | High dose opioid prescribing | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Hip Arthroscopy | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Hip Pain | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Hip Replacement | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Hip Replacement Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
| Homeopathy | All indications | Double Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Homeopathy Patient Information Leaflet | All indications | n/a | Patient information | Hertfordshire and West Essex ICB |
| how to access TARGET resource guide | Guide | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| How to guide: Searching HWE prescribing guidance website | n/a | n/a | Hertfordshire and West Essex ICB | |
| HRT Hormone Replacement Therapy Guidance | HRT | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Human and animal bites | Human and animal bites | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| HWE ICS End of Life Care Anticipatory Prescribing Guidance | Palliative Care | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Hyaluronan, intra-articular injection | Osteoarthritis | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Hybrid Closed Loop Systems for Adults: Local Implementation plans | n/a | Position statement | Hertfordshire and West Essex ICB | |
| Hybrid Closed Loop Systems for Children and Young People aged under 19 years | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Hydrocortisone (Alkindi) | Adrenal insufficiency | Double Red | n/a | Hertfordshire and West Essex ICB |
| Hydrocortisone (Plenadren) | Adrenal insufficiency | Double Red | n/a | Hertfordshire and West Essex ICB |
| Hydroxycarbamide | Sickle Cell Disease | Red | n/a | Hertfordshire and West Essex ICB |
| Hydroxycarbamide | Myeloproliferative neoplasms | Amber protocol | Shared care protocol | Hertfordshire and West Essex ICB |
| Hydroxychloroquine | Rheumatoid arthritis, discoid and systemic lupus erythematosus, and dermatological conditions caused or aggravated by sunlight | Amber initiation | n/a | Hertfordshire and West Essex ICB |
| Hyoscine butylbromide | Irritable bowel syndrome (IBS) 1st line | Green | n/a | Hertfordshire and West Essex ICB |
| Hyperhidrosis | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Hyperhidrosis | Hyperhidrosis - self help | n/a | Patient information | Hertfordshire and West Essex ICB |
| Hyperhidrosis Management | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Hypertension guidelines in adults | Hypertension | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Hypertension in Adults - Diagnosis and Initial Management | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Hysterectomy for heavy menstrual bleeding | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Hysterectomy in Gender Dysphoria | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Hysterectomy In Gender Dysphoria Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
| Hysterectomy Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
| iAluRil | Chronic inflammation or infection of the bladder | Double Red | Decision document | Hertfordshire and West Essex ICB |
| Ibandronic acid - oral | Osteoporosis | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Ibandronic acid 50mg | Prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases. | Amber initiation | n/a | Hertfordshire and West Essex ICB |
| Ibandronic acid IV | Osteoporosis | Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Ibrutinib | Cancer (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Icosapent ethyl | Hypertriglyceridemia | Red | Decision document | Hertfordshire and West Essex ICB |
| ICS wound care formulary | Wound care | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Imatinib | All indications (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Imiquimod 3.75% cream | Actinic keratosis | Double Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Imiquimod 5% cream | Actinic keratosis | Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Immediate Access to Emergency Drugs Scheme | Immediate Access to Emergency Drugs Scheme | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Immediate Release Fentanyl Deprescribing Guide In Primary Care | Pain | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Impetigo | Impetigo | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Implementation Guide for Proactive care in Integrated Neighbourhood Teams | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Incidental Ovarian Cyst | n/a | Clinical pathways | South and West Hertfordshire | |
| Inclisiran | Primary hypercholesterolaemia and mixed dyslipidaemia | Amber initiation | Prescribing support document | Hertfordshire and West Essex ICB |
| Inclisiran | Primary hypercholesterolaemia and mixed dyslipidaemia | Amber initiation | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Inclisiran (letter to providers and GP practices 01/2025) | Primary hypercholesterolaemia and mixed dyslipidaemia | n/a | n/a | Hertfordshire and West Essex ICB |
| Independence dressings | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB | |
| Infections in Primary Care | Infections | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Infertility | n/a | Clinical pathways | East and North Hertfordshire | |
| Inflammatory Bowel Disease (IBD) | n/a | Clinical pathways | East and North Hertfordshire | |
| Infliximab IV | Crohn's disease - moderate to severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Infliximab IV | Axial spondyloarthritis - ankylosing spondylitis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Infliximab IV | Ulcerative colitis - moderate severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Infliximab IV | Psoriasis - moderate severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Infliximab IV | Psoriatic arthritis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Infliximab IV | Rheumatoid arthritis - severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Infliximab IV | Rheumatoid arthritis - moderate | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Infliximab IV biosimilar | Diarrhoea or colitis associated with Immune Checkpoint Inhibitor therapy | Red | Decision document | Hertfordshire and West Essex ICB |
| Influenza | Influenza | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Inhaled corticosteroids | Asthma COPD - ECF FAQs | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Inhaler - environmentally friendly | Asthma COPD | n/a | Patient information | Hertfordshire and West Essex ICB |
| Inhaler reliever | Asthma | n/a | Patient information | Hertfordshire and West Essex ICB |
| Injections and Radiofrequency Denervation for non-specific back pain | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Injections and Radiofrequency Denervation for non-specific back pain Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
| Injections for isolated low back pain without sciatica | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Inositol nicotinate | Intermittent claudication in people with peripheral arterial disease | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Insect bites and stings | Insect bites and stings | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Inspection - CQC | Managing Medicines in a GP Practice | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Insulin Fiasp | Diabetes type 1 | Amber initiation | Decision document | Hertfordshire and West Essex ICB |
| Insulin lispro (Lyumjev) | Diabetes type 1 | Double Red | n/a | Hertfordshire and West Essex ICB |
| Insulin Pumps: Position Statement | n/a | Position statement | Hertfordshire and West Essex ICB | |
| Intranasal corticosteroids | Allergic rhinitis | Green | Decision document | Hertfordshire and West Essex ICB |
| Investigation of Persistent Lower GI symptoms where cancer is not suspected | n/a | Clinical pathways | South and West Hertfordshire | |
| Iron chelators | Blood transfusion related iron overload in patients with myelodysplastic syndrome | Double Red | Decision document | Hertfordshire and West Essex ICB |
| Irritable Bowel Syndrome (IBS) | n/a | n/a | South and West Hertfordshire | |
| Isavuconazole | Antifungal (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Isoniazid | Tuberculosis (NHSE) | Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Isotretinoin | Acne | Red | n/a | Hertfordshire and West Essex ICB |
| Ispaghula husk (Fybogel) | Constipation | Green | n/a | Hertfordshire and West Essex ICB |
| Ivabradine | stable angina and chronic heart failure | Amber initiation | Prescribing support document | Hertfordshire and West Essex ICB |
| Ivacaftor | Cystic fibrosis (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Ivermectin 10mg/ml cream | Papulopustular rosacea | Green | Decision document | Hertfordshire and West Essex ICB |
| IVF drugs | Infertility | Red | n/a | Hertfordshire and West Essex ICB |
| Ixekizumab | Psoriasis - moderate severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| ixekizumab | Psoriatic arthritis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| ixekizumab | Axial spondyloarthritis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Joint Activities with the Pharmaceutical Industry | Pharmaceutical Industry | n/a | Position statement | Hertfordshire and West Essex ICB |
| Kelhale inhaler | Asthma | Green | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Ketone test strip | Diabetic ketoacidosis (DKA) sick day | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Knee Arthroscopy – local supplement | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Knee arthroscopy for patients with osteoarthritis | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Knee Arthroscopy Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
| Knee Pain | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Knee Replacement | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Labiaplasty, Vaginoplasty & Hymenorrhaphy | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Labiaplasty, Vaginoplasty & Hymenorrhaphy Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
| Lacosamide | Epilepsy | Amber initiation | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Lactulose | Constipation | Green | n/a | Hertfordshire and West Essex ICB |
| Lamivudine | Hepatitis B (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Lamotrigine | Epilepsy | Amber initiation | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Lanthanum | Hyperphosphataemia in adult patients with chronic kidney disease | Amber protocol | Shared care protocol | Hertfordshire and West Essex ICB |
| Latanoprost–netarsudil | Glaucoma (primary open-angle) or ocular hypertension | Amber initiation | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Laxido | Constipation | Green | n/a | Hertfordshire and West Essex ICB |
| Learning Disabilities | n/a | Clinical pathways | Hertfordshire and West Essex ICB, South and West Hertfordshire | |
| Lebrikizumab | Atopic dermatitis - moderate to severe | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Leflunomide | Rheumatoid Arthritis, Psoriatic Arthritis | Amber protocol | Shared care protocol | Hertfordshire and West Essex ICB |
| Left Ventricular Systolic Dysfunction (LVSD) Management | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Leg ulcer infection | Leg ulcer infection | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Lenalidomide | Multiple myeloma follicular lymphoma (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Lenograstim | Neutropenia (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Letermovir | Cytomegalovirus (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Letrozole | Familial breast cancer | Amber initiation | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Levemir Discontinuation - System Planning Document | Diabetes | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Levetiracetam | Epilepsy | Amber initiation | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Levothyroxine solution to tablets switch patient letter | hypothyroidism | n/a | Patient information | Hertfordshire and West Essex ICB |
| Lidocaine plaster patient information Leaflet | Pain | n/a | Patient information | Hertfordshire and West Essex ICB |
| Lidocaine Plasters | All except post herpetic neuralgia and non post herpetic neuralgia localised neuropathy | Double Red | n/a | Hertfordshire and West Essex ICB |
| Lidocaine plasters deprescribing guide | Neuropathic pain | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Limping Child | Paediatric | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Linezolid | Antibacterial | Red | n/a | Hertfordshire and West Essex ICB |
| Linzagolix | Uterine Fibroids | Amber initiation | Decision document | Hertfordshire and West Essex ICB |
| Linzagolix | Endometriosis | Amber initiation | Decision document | Hertfordshire and West Essex ICB |
| Liothyronine | Hypothyroidism | Amber protocol | Shared care protocol | Hertfordshire and West Essex ICB |
| Liothyronine - Position Statement | Hypothyroidism | Amber protocol | Position statement | Hertfordshire and West Essex ICB |
| Liothyronine – Information for Patients | Hypothyroidism | Amber protocol | Patient information | Hertfordshire and West Essex ICB |
| Liothyronine Review Algorithm | Hypothyroidism | Amber protocol | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Lipid management | patient decision aid statin therapy | n/a | Patient information | Hertfordshire and West Essex ICB |
| Lipid management pathway | Statin intolerance | n/a | Prescribing pathway | Hertfordshire and West Essex ICB |
| Lipid management pathway | Primary & secondary prevention | n/a | Prescribing pathway | Hertfordshire and West Essex ICB |
| Liposuction | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Liposuction Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
| Liraglutide | Obesity in people aged 12 to 17 years | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Liraglutide | Overweight and obesity management | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Lisdexamfetamine | Attention deficit hyperactivity disorder (ADHD) | Amber protocol | Shared care protocol | East and North Hertfordshire, South and West Hertfordshire |
| Lisdexamfetamine | Attention deficit hyperactivity disorder (ADHD) | Amber protocol | Shared care protocol | West Essex |
| Lithium | Mania, hypomania, bipolar disorder, depression and aggressive or self-harming behaviour | Amber protocol | Shared care protocol | West Essex |
| Lithium | Mania, hypomania, bipolar disorder, depression and aggressive or self-harming behaviour | Amber protocol | Shared care protocol | East and North Hertfordshire, South and West Hertfordshire |
| Lithium Primary Care action plan | Mania, hypomania, bipolar disorder, depression and aggressive or self-harming behaviour | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Liver Function Test (LFT) | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Loin Pain Renal Colic | n/a | n/a | South and West Hertfordshire | |
| Lomitapide | Homozygous familial hypercholesterolaemia (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Long COVID | n/a | Decision document | Hertfordshire and West Essex ICB | |
| Long term insomnia management including Cognitive Behavioural Therapy for insomnia (CBT-I) Frequently Asked Questions (FAQs) for adult patients | Long-term insomnia | n/a | Patient information | Hertfordshire and West Essex ICB |
| Loperamide | Diarrhoea | Green | n/a | Hertfordshire and West Essex ICB |
| Low molecular weight heparin (LMWH) | Anticoagulation | Red | Decision document | Hertfordshire and West Essex ICB |
| Lower GI/Colorectal Cancer Suspected | n/a | Clinical pathways | East and North Hertfordshire, South and West Hertfordshire | |
| Loxapine | Acute agitation and disturbed behaviours associated with schizophrenia and bipolar disorder | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Lung Cancer - Suspected | n/a | Clinical pathways | East and North Hertfordshire, South and West Hertfordshire | |
| Lurasidone | Schizophrenia | Amber initiation | Decision document | Hertfordshire and West Essex ICB |
| Lusutrombopag | Thrombocytopenia in chronic liver disease | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Lutein and Antioxidants | Eye Supplements for AMD | Double Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Lutein and Antioxidants Patient Information Leaflet | Eye Supplements for AMD | n/a | Patient information | Hertfordshire and West Essex ICB |
| Lycra Dynamic Splinting for Children with Neurological Impairment | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Lymphoedema Services – Specialist treatment in the private sector | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Macitentan | Pulmonary arterial hypertension (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Macrogol | Constipation | Green | n/a | Hertfordshire and West Essex ICB |
| Macular oedema secondary to retinal vein occlusion (branch RVO or central RVO) | Macular oedema secondary to retinal vein occlusion (branch RVO or central RVO) | Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Male LUTS | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Management of MSK conditions in patients with previous cancer | n/a | Clinical pathways | South and West Hertfordshire | |
| Management of Unscheduled Bleeding on Hormone Replacement Therapy (HRT) | n/a | Clinical pathways | South and West Hertfordshire | |
| Managing malnutrition - Additional guidance | Nutrition support - Malnutrition | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Mannitol dry powder for inhalation | Cystic fibrosis (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| MAR Prompt Poster | Care homes | n/a | Prescribing support document | Hertfordshire and West Essex ICB |
| Mastitis | Mastitis | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Mebeverine - immediate release (IR) | Irritable bowel syndrome (IBS) 1st line | Green | n/a | Hertfordshire and West Essex ICB |
| Mebeverine - modified release (MR) | Irritable bowel syndrome (IBS) | Double Red | n/a | Hertfordshire and West Essex ICB |
| Mecasermin | Growth failure (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Mechanical Insufflation-Exsufflation (MI-E) Devices / CoughAssist | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Medication Overuse Headache | n/a | Decision document | South and West Hertfordshire | |
| Medication Shortages | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB | |
| Medicines Management & Prescribing Self-Assessment Tool | Managing Medicines in a GP Practice - CQC | n/a | n/a | Hertfordshire and West Essex ICB |
| Melatonin | Insomnia adults excluding learning disabilities | Double Red | n/a | Hertfordshire and West Essex ICB |
| Melatonin | Insomnia - Neurodevelopmental Disorders in patients under the age of 18 years | Amber initiation | Prescribing support document | Hertfordshire and West Essex ICB |
| Melatonin | Insomnia - Learning disability in adults and paediatrics | Amber initiation | Prescribing support document | Hertfordshire and West Essex ICB |
| Melatonin | Insomnia - product options in neurodevelopmental disorders in patients aged 2 to under 18 years | Amber initiation | Prescribing guideline | Hertfordshire and West Essex ICB |
| Melatonin | Insomnia - product options in adult and paediatric patients with learning disabilities | Amber initiation | Prescribing guideline | Hertfordshire and West Essex ICB |
| Melatonin (Slenyto) | Insomnia | Double Red | Decision document | Hertfordshire and West Essex ICB |
| Melphalan | Cancer (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Memantine | Alzheimer's disease dementia | Amber initiation | Prescribing support document | East and North Hertfordshire, South and West Hertfordshire |
| Memantine | Alzheimer's disease dementia | Amber protocol | Shared care protocol | West Essex |
| Meningitis | Meningitis - prevention of secondary case | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Meningococcal disease | Meningococcal disease - suspected | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Mepacrine (unlicensed medicine) | Subacute cutaneous and Discoid lupus erythematosus | Red | n/a | Hertfordshire and West Essex ICB |
| Mercaptamine | Corneal cystine deposits (NHSE) | Red | n/a | Hertfordshire and West Essex ICB |
| Mesalazine - Octasa preferred 1st choice | Inflammatory bowel disease | Green | n/a | Hertfordshire and West Essex ICB |
| Mesalazine -Mezavant | Inflammatory bowel disease | Double Red | n/a | Hertfordshire and West Essex ICB |
| Mesna | Cancer (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Metformin | Diabetes type 2 | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Metformin oral solution to tablets switch patient letter | Diabetes | n/a | Patient information | Hertfordshire and West Essex ICB |
| Methenamine | Recurrent adult | Amber initiation | Prescribing guideline | Hertfordshire and West Essex ICB |
| Methotrexate | Autoimmune disease | Amber protocol | Shared care protocol | West Essex |
| Methotrexate | Autoimmune disease | Amber protocol | Shared care protocol | East and North Hertfordshire, South and West Hertfordshire |
| Methotrexate 10mg | Autoimmune disease | Double Red | n/a | Hertfordshire and West Essex ICB |
| Methotrexate 2.5mg | Autoimmune disease | Amber protocol | Prescribing guideline | Hertfordshire and West Essex ICB |
| Methoxsalen | Cancer, psoriasis | Red | n/a | Hertfordshire and West Essex ICB |
| Methylnaltrexone bromide | Opioid induced bowel dysfunction | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Methylnaltrexone bromide | Constipation - opioid induced | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Methylphenidate | Attention deficit hyperactivity disorder (ADHD) | Amber protocol | Shared care protocol | East and North Hertfordshire, South and West Hertfordshire |
| Methylphenidate | Attention deficit hyperactivity disorder (ADHD) | Amber protocol | Shared care protocol | West Essex |
| Methylphenidate | Narcolepsy (tertiary centre only) some have agreed amber protocol | Amber initiation | n/a | Hertfordshire and West Essex ICB |
| Metolazone | Oedema | n/a | Patient information | Hertfordshire and West Essex ICB |
| Metolazone | Oedema | Red | Decision document | Hertfordshire and West Essex ICB |
| Mexiletine | Myotonia in non-dystrophic myotonic disorders (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Mexiletine | Life threatening ventricular arrhythmias (unlicensed - acute provider only) | Red | n/a | Hertfordshire and West Essex ICB |
| Midazolam (Buccolam) | Epilepsy (prescribe by brand) | Amber initiation | Prescribing guideline | Hertfordshire and West Essex ICB |
| Midazolam (Epistatus) | Epilepsy (prescribe by brand) | Amber initiation | Prescribing guideline | Hertfordshire and West Essex ICB |
| Midodrine | Orthostatic Hypotension | Amber initiation | Prescribing support document | Hertfordshire and West Essex ICB |
| Migraine | Migraine - chronic | n/a | Prescribing pathway | Hertfordshire and West Essex ICB |
| Migraine | Migraine - episodic | n/a | Prescribing pathway | Hertfordshire and West Essex ICB |
| Migraine in Adults | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Migraine treatment in adults | Migraine | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Migraine treatment in adults | Migraine | n/a | Patient information | Hertfordshire and West Essex ICB |
| Minocycline | Acne | Double Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Minocycline Patient information leaflet | Acne | n/a | Patient information | Hertfordshire and West Essex ICB |
| Mirabegron | neurogenic detrusor overactivity in people 3 to 17 years | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Mirena levonorgestrel-releasing intrauterine system (IUS) | Contraception | Green | Decision document | Hertfordshire and West Essex ICB |
| Mirikizumab | Ulcerative colitis - moderate severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Mirtazapine dose optimisation switch patient letter | Green | Patient information | Hertfordshire and West Essex ICB | |
| Mitomycin | Cancer (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Mitotane | Cancer (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Modafinil | Narcolepsy (tertiary centre only) some have agreed amber protocol | Amber initiation | n/a | Hertfordshire and West Essex ICB |
| Modern Slavery and Human Trafficking | n/a | Patient information | Hertfordshire and West Essex ICB | |
| Molnupiravir | COVID-19 (CMDU only) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Mometasone 50micrograms/dose nasal spray | Allergic rhinitis 1st line | Green | Decision document | Hertfordshire and West Essex ICB |
| Motor Neurone Disease (MND) | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Multi-compartment compliance aid and 7-day prescription guidance | Multi-compartment compliance aid | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Multi-compartment Compliance Aids | Provider/Trust Communication Bulletin | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Multi-compartment Compliance Aids | FAQs | n/a | Prescribing support document | Hertfordshire and West Essex ICB |
| Multi-compartment Compliance Aids | GP Practice Communication Bulletin | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Multi-compartment Compliance Aids | Carer Communication Bulletin | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Multi-compartment Compliance Aids | Reasonable adjustment | n/a | Prescribing pathway | Hertfordshire and West Essex ICB |
| Multi-compartment Compliance Aids | Assessment tool | n/a | n/a | Hertfordshire and West Essex ICB |
| Multi-compartment Compliance Aids | Patient information | n/a | Patient information | Hertfordshire and West Essex ICB |
| Multiple Sclerosis (MS) | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Mycophenolate mofetil | Multisystem autoimmune disease | Amber protocol | Shared care protocol | West Essex |
| Mycophenolate mofetil | Multisystem autoimmune disease | Amber protocol | Shared care protocol | East and North Hertfordshire, South and West Hertfordshire |
| Nabilone | Intractable chemotherapy induced nausea and vomiting | Red | Decision document | Hertfordshire and West Essex ICB |
| Naftidrofuryl Oxalate | Intermittent claudication in people with peripheral arterial disease | Green | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Naldemedine | Constipation - opioid induced | Green | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Nalmefene | Reduction of alcohol consumption in adult patients who have a high drinking risk level without physical withdrawal risk | Amber initiation | Decision document | West Essex |
| Nalmefene | Reduction of alcohol consumption in adult patients who have a high drinking risk level without physical withdrawal risk | Red | Decision document | East and North Hertfordshire, South and West Hertfordshire |
| Naloxegol | Constipation - opioid induced | Green | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Naltrexone–bupropion | Overweight and obesity | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Nasal Surgery | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Nasal Surgery Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
| Natalizumab | Multiple sclerosis (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Neck Pain | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Needles for pre-filled / reusable insulin or GLP-1 receptor agonist pens | Diabetes | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Needles Patient Information Leaflet | Diabetes | n/a | Patient information | Hertfordshire and West Essex ICB |
| Nemolizumab | Atopic dermatitis - moderate severe | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Nephrotrans® (sodium hydrogen carbonate gastro-resistant 500mg capsules) | Metabolic acidosis in adults with chronic kidney disease | Amber initiation | Decision document | Hertfordshire and West Essex ICB |
| Neuropathic pain | Neuropathic pain | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Neuropathic Pain Drug Titration and Review | n/a | Clinical pathways | East and North Hertfordshire | |
| Nevirapine | AIDS/ HIV Antiretroviral (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| NICE NG28 Visual summary on choosing medicines for type 2 diabetes in adults | Type 2 diabetes | n/a | Prescribing pathway | Hertfordshire and West Essex ICB |
| Nicotinic acid | Prevention of CVD | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Nintedanib | Cancer (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Nirmatrelvir plus ritonavir | COVID-19 (CMDU only) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Nitazoxanide | Viral hepatitis (B&C) and respiratory syncytial virus (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Nitrazepam | Insomnia | Double Red | n/a | Hertfordshire and West Essex ICB |
| Nitrofurantoin oral solution to capsules switch Patient Letter | urinary tract infection | n/a | Patient information | Hertfordshire and West Essex ICB |
| Non-Alcoholic Fatty Liver Disease (NAFLD) | n/a | Clinical pathways | East and North Hertfordshire, South and West Hertfordshire | |
| Non-Medical Prescriber Guidance | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB | |
| Nose Bleeds | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Nutritional product/vitamin supplement prescribing - Position statement | Nutrition support - Malnutrition & Vitamin insufficiency | n/a | Position statement | Hertfordshire and West Essex ICB |
| Obeticholic acid | Primary biliary cholangitis (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Ocriplasmin | Vitreomacular traction | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Omalizumab | Urticaria - severe chronic | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Omega 3 fatty acid | Primary or secondary prevention of CVD, sleep problems, multiple sclerosis (MS), familial hypercholesterolemia | Double Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Omega 3 fatty acid | Hypertriglyceridaemia - severe | Amber initiation | Decision document | Hertfordshire and West Essex ICB |
| Omega-3 Fatty Acids Patient Information Leaflet | Primary or secondary prevention of CVD, sleep problems, multiple sclerosis (MS), familial hypercholesterolemia | n/a | Patient information | Hertfordshire and West Essex ICB |
| Omeprazole switch paediatric patient letter | Gastrointestinal disorders | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Omeprazole switch PEG or NG patient letter | Gastrointestinal disorders | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Open MRI | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Open Mri Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
| Opicapone | Parkinson's disease | Amber initiation | n/a | Hertfordshire and West Essex ICB |
| Opioid | Pain - persistent self care | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Opioid | Pain - plan agreement | n/a | Patient information | Hertfordshire and West Essex ICB |
| Opioid | Pain - review letter | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Opioid Aware Campaign | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB | |
| Opioid Deprescribing | Pain - long-term prescribing for non-cancer, chronic pain in adults | n/a | Position statement | Hertfordshire and West Essex ICB |
| Opioid fact sheet | Pain | Green | Patient information | Hertfordshire and West Essex ICB |
| Opioid Induced Constipation | Opioid Induced Constipation | n/a | Prescribing pathway | Hertfordshire and West Essex ICB |
| Opioid reduction | Opioid reduction tool | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Optimising Prescribing in Diabetes - Quick Reference Guide | Diabetes | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Orphenadrine | Parkinson's disease | Amber initiation | n/a | Hertfordshire and West Essex ICB |
| Osteoporosis | Osteoporosis | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Otigo (anaesthetic and analgesic) | Otitis media | Double Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Otitis externa | Otitis externa - acute | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Otitis Externa | n/a | Clinical pathways | East and North Hertfordshire | |
| Otitis media | Otitis media - acute | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Ovarian Cancer | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Over The Counter Medicines | Addendum to NHSE | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Over The Counter Medicines (OTC) | NHSE guidance | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Over The Counter Medicines (OTC) | OTC - When to prescribe | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Over the counter medicines for minor health conditions – Information for patients | OTC | n/a | Patient information | Hertfordshire and West Essex ICB |
| Overprescribing and reducing harm from medicines Q&A | n/a | Prescribing support document | Hertfordshire and West Essex ICB | |
| Oxcarbazepine | Epilepsy | Amber initiation | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Oxybutynin oral solution to Tablets switch Patient Letter | urinary incontinence | n/a | Patient information | Hertfordshire and West Essex ICB |
| Oxycodone and naloxone | Pain | Double Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Oxycodone and Naloxone combination products Patient Information Leaflet | Pain | n/a | Patient information | Hertfordshire and West Essex ICB |
| Oxygen | Home oxygen | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Oxygen | Cluster headache | n/a | Decision document | Hertfordshire and West Essex ICB |
| Ozanimod | Ulcerative colitis - moderate severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| PADM claiming | vaccinations | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Paed CMPA - 1. HCP guidance | Paediatric Nutrition – CMPA | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Paed CMPA - Breastfeeding: Parent/carer guidance | Paediatric Nutrition – CMPA | n/a | Patient information | Hertfordshire and West Essex ICB |
| Paed CMPA - Formula flow chart | Paediatric Nutrition – CMPA | n/a | Prescribing support document | Hertfordshire and West Essex ICB |
| Paed CMPA - GP FAQs | Paediatric Nutrition – CMPA | n/a | Prescribing support document | Hertfordshire and West Essex ICB |
| Paed CMPA - Parent/carer FAQs | Paediatric Nutrition – CMPA | n/a | Patient information | Hertfordshire and West Essex ICB |
| Paed CMPA - Reviews: ECF Q&A's | Paediatric Nutrition – CMPA | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Paed CMPA - Stopping formula at 1 year: GP guidance | Paediatric Nutrition – CMPA | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Paed CMPA - Stopping formula at 1 year: Parent/carer guidance | Paediatric Nutrition - CMPA | n/a | Patient information | Hertfordshire and West Essex ICB |
| Paed CMPA - Stopping formula at 1 year: Parent/carer letter | Paediatric Nutrition - CMPA | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Paediatric Abdominal Pain | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Paediatric Acute Otitis Media | n/a | Clinical pathways | South and West Hertfordshire | |
| Paediatric Asthma | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Paediatric Constipation | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Paediatric Diarhoea and Vomitting | n/a | n/a | Hertfordshire and West Essex ICB | |
| Paediatric Fever | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Paediatric Lymphadenopathy | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Paediatric Nasal Congestion | n/a | Decision document | South and West Hertfordshire | |
| Paediatric Obstructive Sleep Apnoea | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Paediatric Sepsis | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Paediatric Suspected Bronchiolitis | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Paediatric Suspected Diabetes Same Day Referral Pathway - Children and Young People (CYP) 0-18 years | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Paediatric Suspected UTI | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Palbociclib | Cancer (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Palforzia | Peanut allergy (Specialist allergy centre) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Palliative care formulary | Palliative care | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Palpitations | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Panton-Valentine leukocidin (PVL) | Panton-Valentine leukocidin (PVL) | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Paracetamol and tramadol | Pain | Double Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Paracetamol and Tramadol combination products Patient Information Leaflet | Pain | n/a | Patient information | Hertfordshire and West Essex ICB |
| Paricalcitol | Hyperparathyroidism (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Pathological Demand Avoidance | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Patiromer | Hyperkalaemia of CKD | Amber initiation | Prescribing pathway | Hertfordshire and West Essex ICB |
| Payments for vaccines | vaccinations | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Pegfilgrastim | Neutropenia (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Peginterferon and ropeginterferon | Hepatitis and Multiple sclerosis (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Peginterferon and ropeginterferon | Myeloproliferative neoplasms (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Pegvisomant | Acromegaly (NHSE tertiary centre only) | Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Pelvic inflammatory disease (PID) | Pelvic inflammatory disease (PID) | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Pelvic Mass/Cancer | UI Physical Assessment | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Pen needles switch patient letter | Diabetes | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Penicillamine | Rheumatoid Arthiritis | Amber protocol | n/a | Hertfordshire and West Essex ICB |
| Penicillamine | Tertiary care indication (NHSE) | Amber protocol | n/a | Hertfordshire and West Essex ICB |
| Penile Circumcision | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Pentosan polysulfate sodium | Bladder pain syndrome | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Pentoxifylline | Intermittent claudication in people with peripheral arterial disease | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Peppermint oil | Irritable bowel syndrome (IBS) 1st line | Green | n/a | Hertfordshire and West Essex ICB |
| Pericoronitis | Pericoronitis | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Perindopril arginine | Heart failure, hypertension and prophylaxis of CV events | Double Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Perindopril Arginine Patient information leaflet | Heart failure, hypertension and prophylaxis of CV events | n/a | Patient information | Hertfordshire and West Essex ICB |
| Peyronie’s Disease | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Pharmacy First | Pharmacy First | n/a | n/a | Hertfordshire and West Essex ICB |
| Pharmacy First referral decision aid | n/a | Decision document | Hertfordshire and West Essex ICB | |
| Phenindione | Anticoagulant therapy in the prophylaxis of systemic embolisation in patients with rheumatic heart disease and atrial fibrillation, for prophylaxis after insertion of prosthetic heart valves and for prophylaxis and treatment of venous thrombosis and pulmonary embolism. | Double Red | Decision document | Hertfordshire and West Essex ICB |
| Phenobarbital | Epilepsy | Amber initiation | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Phenytoin | Epilepsy | Green | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Phosphate enema (Cleen) | Constipation | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Pigmanorm | Melasma | Double Red | Decision document | Hertfordshire and West Essex ICB |
| Pirfenidone | Idiopathic pulmonary fibrosis (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Pitolisant | Excessive daytime sleepiness caused by obstructive sleep apnoea | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Plastics Referral Pathway (including scar revision) | n/a | Patient information | Hertfordshire and West Essex ICB | |
| Pneumonia | Pneumonia - community acquired | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Pneumonia | Pneumonia - hospital acquired | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Posaconazole | Fungal infections (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Post-Menopausal Bleeding Management | n/a | Clinical pathways | East and North Hertfordshire | |
| Postcoital Bleeding in Pre-Menopausal Women | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Potassium binders | Hyperkalaemia of CKD | Amber initiation | Prescribing pathway | Hertfordshire and West Essex ICB |
| Practice support - Memorandum of understanding between GP practices and medicines optimisation team | n/a | n/a | Hertfordshire and West Essex ICB | |
| Pramipexole | Parkinson's disease | Amber initiation | n/a | Hertfordshire and West Essex ICB |
| Prasugrel | Percutaneous coronary intervention (PCI) for treating acute coronary syndromes (ACS) | Amber initiation | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Pre Diabetes | n/a | Patient information | Hertfordshire and West Essex ICB | |
| Prednisolone | All indications - soluble tablet | n/a | Patient information | Hertfordshire and West Essex ICB |
| Prednisolone enteric coated | All indications | Double Red | n/a | Hertfordshire and West Essex ICB |
| Prescribing of GLP1 Receptor Agonists for Weight Loss – Restricted | Weight management | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Prescription | Private consultation | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Prescription - NHSBSA | Organisation and prescriber changes | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Prescription - repeat | Clerks hints and tips | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Prescription - repeat | Prescriber guide with tips | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Prescription duration | Decision aid | n/a | Prescribing pathway | Hertfordshire and West Essex ICB |
| Prescription duration 7 days | Process and communication for identification | n/a | Prescribing pathway | Hertfordshire and West Essex ICB |
| Prescription duration guidance | Prescription duration guidance | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Primidone | Epilepsy | Amber initiation | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Probiotics | Irritable bowel syndrome (IBS) | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Probiotics | Treatment or prevention of diarrhoea of any cause. | Double Red | Decision document | Hertfordshire and West Essex ICB |
| Procyclidine | Parkinson's disease | Green | n/a | Hertfordshire and West Essex ICB |
| Prolonged Jaundice Screen | n/a | Clinical pathways | South and West Hertfordshire | |
| Promethazine | All indications | n/a | Position statement | Hertfordshire and West Essex ICB |
| Prostate Cancer - Suspected | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Prostatitis | Prostatitis - acute | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Proton pump inhibitor (PPI) Stopping Or Reducing patient letter | Gastroprotection | n/a | Patient information | Hertfordshire and West Essex ICB |
| Proton pump inhibitor (PPI) and Anticoagulants | Gastroprotection | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Proton pump inhibitor (PPI) and Antiplatelets | Gastroprotection | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Proton pump inhibitor (PPI) and Corticosteroids | Gastroprotection | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Proton pump inhibitor (PPI) and NSAIDS | Gastroprotection | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Proton pump inhibitor (PPI) deprescribing algorithm | Gastroprotection | n/a | Prescribing support document | Hertfordshire and West Essex ICB |
| Proton Pump Inhibitor (PPIs) -Appropriate Prescribing and Deprescribing- Q&A ECF 2025-26 | Gastroprotection | n/a | Prescribing support document | Hertfordshire and West Essex ICB |
| Proton pump inhibitors (PPI) - paediatric | Gastro-protection - paediatric | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| PSA Pathway | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Psoriasis | Psoriasis - severe localised | Red | Decision document | Hertfordshire and West Essex ICB |
| Psoriasis | Psoriasis - moderate severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Psoriasis Topical Treatment - Adults | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Psoriatic Arthritis | Psoriatic Arthritis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Pulmonary Rehabilitation | n/a | Clinical pathways | East and North Hertfordshire | |
| Pyelonephritis | Pyelonephritis - acute upper urinary tract | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Pyrazinamide | Tuberculosis (NHSE) | Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Q&A for Prescribing of Antidepressants for Depression | Depression | n/a | Prescribing support document | Hertfordshire and West Essex ICB |
| Qtern | Diabetes type 2 | Double Red | Decision document | Hertfordshire and West Essex ICB |
| Quetiapine | Schizophrenia and bipolar disorder | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Quick Reference Guide – Optimising Prescribing in Respiratory | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB | |
| Raloxifene | Familial breast cancer | Amber initiation | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Raloxifene | Osteoporosis | Amber initiation | Prescribing guideline | Hertfordshire and West Essex ICB |
| Raltegravir | HIV Antiretroviral (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Ranibizumab | Diabetic retinopathy | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Ranibizumab | Choroidal neovascularisation (CNV) associated with pathological myopia | Red | Decision document | Hertfordshire and West Essex ICB |
| Ranibizumab | Wet AMD | Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Ranibizumab biosimilar | Diabetic macular oedema | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Ranibizumab biosimilar | Macular oedema secondary to retinal vein occlusion (branch RVO or central RVO) | Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Ranolazine | Angina stable | Amber initiation | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Rapid Onset Isolated Visual Loss (No other neurological symptoms or signs) | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Rasagiline | Parkinson's disease | Amber initiation | n/a | Hertfordshire and West Essex ICB |
| Rebates and National Procurement Pricing Agreements | n/a | n/a | Position statement | Hertfordshire and West Essex ICB |
| Recording medications prescribed by other parties on GP clinical systems | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB | |
| Reducing medicines waste in care homes - Care home staff | Care homes | n/a | Prescribing support document | Hertfordshire and West Essex ICB |
| Reducing medicines waste in care homes - GP Practice Staff & Prescribers | Care homes | n/a | Prescribing support document | Hertfordshire and West Essex ICB |
| Referral and Surgery for Snoring, Sleep Disordered Breathing and Obstructive Sleep Apnoea | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Referral to Consultant-Led Tier 3 Weight Management Services | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Referral to Tier 4 Obesity Management Services (Bariatric Surgery) | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
| Referrals for Plastic Surgery - Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
| Relugolix (Orgovyx) | Prostate cancer - hormone-sensitive | Amber initiation | Decision document | Hertfordshire and West Essex ICB |
| Relugolix (Orgovyx) | Prostate cancer - hormone-sensitive | Amber initiation | Prescribing support document | Hertfordshire and West Essex ICB |
| Relugolix (Orgovyx) | Hormone-sensitive prostate cancer | Amber initiation | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Relugolix-estradiol-norethisterone acetate (Ryeqo) | Uterine fibroids | Amber initiation | Decision document | Hertfordshire and West Essex ICB |
| Relugolix-estradiol-norethisterone acetate (Ryeqo) | Endometriosis | Amber initiation | Decision document | Hertfordshire and West Essex ICB |
| Remdesivir | COVID‑19 | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Removal of adenoids for treatment of glue ear | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Repeat Prescribing Toolkit Q&A ECF 2025/26 | Toolkit ECF FAQ | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Residential exercise therapy/rehabilitation courses for the management of Ankylosing Spondylitis | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Respiratory Conditions Referral Pathway | n/a | n/a | South and West Hertfordshire | |
| Reusable Insulin Pen Device Guide | Diabetes | Green | Prescribing support document | Hertfordshire and West Essex ICB |
| Reversal of Sterilisation | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Revision Surgery for Hip & Knee Replacements | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Rheumatoid Arthritis - moderate | Rheumatoid Arthritis - moderate | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Rheumatoid Arthritis - severe | Rheumatoid Arthritis - severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Rhinitis | Adults | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Rhinitis of Newborn | n/a | Clinical pathways | South and West Hertfordshire | |
| Rifampicin | Tuberculosis (NHSE) | Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Rifaximin | Hepatic encephalopathy | Amber initiation | Decision document | Hertfordshire and West Essex ICB |
| Riluzole | Amyotrophic Lateral Sclerosis (ALS) form of Motor Neurone Disease (MND) | Amber protocol | Shared care protocol | Hertfordshire and West Essex ICB |
| Rimegepant | Migraine - acute treatment | Green | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Rimegepant | Migraine- episodic - prevention | Amber initiation | Prescribing pathway | Hertfordshire and West Essex ICB |
| Rimegepant | Migraine- episodic - prevention | Amber initiation | Prescribing support document | Hertfordshire and West Essex ICB |
| Risankizumab | Crohn's disease - moderate to severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Risankizumab | Psoriasis - moderate severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Risankizumab | Ulcerative colitis - moderate severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Risedronate | Osteoporosis | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Risk feeding - Identification & management | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Risperidone dose optimisation switch patient letter | Green | Decision document | Hertfordshire and West Essex ICB | |
| Ritlecitinib | Alopecia Areata - Severe | Red | Decision document | Hertfordshire and West Essex ICB |
| Ritonavir | AIDS/ HIV Antiretroviral (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Rituximab | Autoimmune haemolytic anaemia (AIHA) | Red | Decision document | Hertfordshire and West Essex ICB |
| Rituximab | Rheumatoid arthritis - severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Rivaroxaban | Prevention of atherothrombotic events in patients after an acute coronary syndrome | Amber initiation | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Rivaroxaban | Preventing atherothrombotic events in people with coronary or peripheral artery disease | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Rivastigmine | Alzheimer's disease dementia | Amber initiation | Prescribing support document | East and North Hertfordshire, South and West Hertfordshire |
| Rivastigmine | Alzheimer's disease dementia | Amber protocol | Shared care protocol | West Essex |
| Roflumilast | COPD | Amber initiation | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Romiplostim | Chronic immune thrombocytopenia | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Romosozumab | Osteoporosis | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Ropinirole | Parkinson's disease | Amber initiation | n/a | Hertfordshire and West Essex ICB |
| Rotator Cuff Injury or Inflammation | n/a | Clinical pathways | South and West Hertfordshire | |
| Rotigotine | Parkinson's disease | Amber initiation | n/a | Hertfordshire and West Essex ICB |
| Roxadustat | Anaemia with chronic kidney disease | Red | Decision document | Hertfordshire and West Essex ICB |
| Rubefacients, benzydamine, mucopolysaccharide and cooling products (excluding topical NSAIDs and capsaicin) | Musculoskeletal pain | Double Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Ruxolitinib | Polycythaemia vera (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Ruxolitinib | Myelofibrosis (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Ruxolitinib cream | Non-segmental vitiligo | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Sacubitril valsartan | Heart failure | Amber initiation | Prescribing support document | Hertfordshire and West Essex ICB |
| Safeguarding | n/a | Patient information | Hertfordshire and West Essex ICB | |
| Safety needles letter | Diabetes | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Salamol - letter | Asthma COPD | Green | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Salamol - poster | Asthma COPD | Green | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Sarcoma - Suspected Cancer | n/a | Clinical pathways | East and North Hertfordshire | |
| Sarilumab | Rheumatoid arthritis - severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Sativex® and other licensed cannabis -based medicinal products | Red | Decision document | Hertfordshire and West Essex ICB | |
| Sayana Press | Contraception | Green | Decision document | Hertfordshire and West Essex ICB |
| Scabies | Scabies | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Scar Revision | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Scar Revision Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
| Scarlet fever (GAS) | Scarlet fever (GAS) | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Schools | Medicines in schools FAQs | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| ScriptSwitch | Process simple switches | n/a | Decision document | Hertfordshire and West Essex ICB |
| Scriptswitch | Implementation for practices | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Seasonal Allergic Rhinitis (Hay Fever) | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Secukinumab | Psoriasis - moderate severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Secukinumab | Psoriatic arthritis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Secukinumab | Axial spondyloarthritis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Selective serotonin reuptake inhibitors (SSRIs) | Irritable bowel syndrome (IBS) 3rd line unlicensed | Green | n/a | Hertfordshire and West Essex ICB |
| Selective serotonin reuptake inhibitors (SSRIs) | Narcolepsy (tertiary centre only) some have agreed amber protocol | Amber initiation | n/a | Hertfordshire and West Essex ICB |
| Selegiline | Parkinson's disease | Amber initiation | n/a | Hertfordshire and West Essex ICB |
| Semaglutide | Overweight and obesity management - adults | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Semaglutide | Overweight and obesity management - young people aged 12 to 17 years | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Semaglutide | Diabetes type 2 | n/a | Patient information | Hertfordshire and West Essex ICB |
| Senna | Constipation | Green | n/a | Hertfordshire and West Essex ICB |
| Seroquel 100mg tablets to generic-switch-letter | Schizophrenia/Bipolar | n/a | Patient information | Hertfordshire and West Essex ICB |
| Sevelamer | Hyperphosphateemia in adult patients with chronic kidney disease | Amber protocol | Shared care protocol | Hertfordshire and West Essex ICB |
| Sexual Health Pathway | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| SGLT2 inhibitors | Diabetes type 2 | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Shared Care | Shared Care Principles | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Shared care | Attention deficit hyperactivity disorder (ADHD) by Private Provider | Amber protocol | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Shared care | Initiation by a Private Provider | Amber protocol | Patient information | Hertfordshire and West Essex ICB |
| Shortage of Pancreatic Enzyme Replacement Therapy (PERT) Shortage Information - Community Pharmacy | PERT Shortage | n/a | Prescribing support document | Hertfordshire and West Essex ICB |
| Shortage of Pancreatic Enzyme Replacement Therapy (PERT) Shortage Information - General Practice | PERT Shortage | n/a | Prescribing support document | Hertfordshire and West Essex ICB |
| Shoulder Arthroscopy | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Shoulder Arthroscopy Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
| Shoulder Instability Pathway | n/a | n/a | South and West Hertfordshire | |
| Shoulder Pain | n/a | Clinical pathways | Hertfordshire and West Essex ICB, South and West Hertfordshire | |
| Sildenafil (20mg tablets) | Pulmonary arterial hypertension (NHSE) | Red | n/a | Hertfordshire and West Essex ICB |
| Silk Garments | Eczema dermatitis | n/a | Patient information | Hertfordshire and West Essex ICB |
| Silk garments | Eczema dermatitis | Double Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Silver dressings | Wound Care | n/a | Position statement | Hertfordshire and West Essex ICB |
| Simultaneous Joint Replacement | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Sinusitis | Sinusitis | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Sinusitis and Facial Pain | Adults | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Siponimod | Multiple sclerosis (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Sirolimus oral | Transplant rejection (prescribe by brand) NHSE for existing patients | Amber protocol | n/a | Hertfordshire and West Essex ICB |
| Sitagliptin | Diabetes type 2 | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Sitagliptin | Diabetes type 2 | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Skin Cancer Suspected - Pigmented Lesion/ Melanoma/ SCC/ BCC | n/a | Patient information | Hertfordshire and West Essex ICB | |
| Skin Tears | n/a | Clinical pathways | East and North Hertfordshire | |
| Sleep Apnoea | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Snoring and Sleep Apnoea Management in Adults | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Sodium clodronate | Bone pain, hypercalcaemia of malignancy | Amber initiation | n/a | Hertfordshire and West Essex ICB |
| Sodium cromoglicate | Food allergy | Double Red | Decision document | Hertfordshire and West Essex ICB |
| Sodium oxybate | Narcolepsy with cataplexy (tertiary centre only) | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Sodium valproate | All indications | Amber initiation | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Sodium zirconium | Hyperkalaemia of CKD | Amber initiation | Prescribing pathway | Hertfordshire and West Essex ICB |
| Solid Oral Dosage Forms in Children | n/a | Position statement | Hertfordshire and West Essex ICB | |
| Solriamfetol | Excessive daytime sleepiness caused by narcolepsy (tertiary centre only) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Solriamfetol apnoea | Excessive daytime sleepiness caused by obstructive sleep apnoea | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Somapacitan | Growth disturbance caused by growth hormone deficiency in children | Red | Decision document | Hertfordshire and West Essex ICB |
| Somatrogon (Ngenla) | Growth disturbance caused by growth hormone deficiency in children | Red | Decision document | Hertfordshire and West Essex ICB |
| Somatropin | Treatment of adults with growth hormone deficiency | Amber protocol | Shared care protocol | Hertfordshire and West Essex ICB |
| Somatropin | Treatment of growth failure in children | Amber protocol | Shared care protocol | Hertfordshire and West Essex ICB |
| Sore throat | Sore throat - acute | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Spacer | Asthma COPD | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Sparsentan | Primary IgA nephropathy | Red | Decision document | Hertfordshire and West Essex ICB |
| Specialist / Non-approved / Non-Formulary Medicines – Information for Patients | Patient information | n/a | Patient information | Hertfordshire and West Essex ICB |
| Specialist or non-approved drug response letter from GP to Trust | n/a | n/a | Hertfordshire and West Essex ICB | |
| Specials alternative guidance | Specials alternative guidance | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Spesolimab | Psoriasis - Pustular flares | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Spinal and Low Back Pain |SWH | n/a | Clinical pathways | South and West Hertfordshire | |
| Spinal Cord Stimulation | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Statin patient decision aid - NICE | Hypercholesterolaemia | n/a | Patient information | Hertfordshire and West Essex ICB |
| Steroid card | FAQs | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| STI screening | STI screening | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Stoma - accessories not for prescribing | Stoma | n/a | Patient information | East and North Hertfordshire, South and West Hertfordshire |
| Stoma - accessories not for prescribing | Stoma | Double Red | Position statement | Hertfordshire and West Essex ICB |
| Stoma - adhesive remover spray | Stoma | n/a | Patient information | East and North Hertfordshire, South and West Hertfordshire |
| Stoma - adhesive remover spray wipes | Stoma | Green | Position statement | Hertfordshire and West Essex ICB |
| Stoma - adhesive remover wipes to spray | Stoma | n/a | Patient information | East and North Hertfordshire, South and West Hertfordshire |
| Stoma - adhesive remover wipes to wipes | Stoma | n/a | Patient information | East and North Hertfordshire, South and West Hertfordshire |
| Stoma - adhesive spray lotion | Stoma | Double Red | Position statement | Hertfordshire and West Essex ICB |
| Stoma - adhesive spray lotion | Stoma | n/a | Patient information | East and North Hertfordshire, South and West Hertfordshire |
| Stoma - Appliance Ordering Information for Patients | Stoma - DAC | n/a | Patient information | Hertfordshire and West Essex ICB |
| Stoma - barrier cream | Stoma | n/a | Patient information | East and North Hertfordshire, South and West Hertfordshire |
| Stoma - barrier cream | Stoma | Green | Position statement | Hertfordshire and West Essex ICB |
| Stoma - barrier ring seal washer | Stoma | n/a | Patient information | East and North Hertfordshire, South and West Hertfordshire |
| Stoma - barrier ring seal washer | Stoma | Green | Position statement | Hertfordshire and West Essex ICB |
| Stoma - collars | Stoma | n/a | Patient information | East and North Hertfordshire, South and West Hertfordshire |
| Stoma - collars | Stoma | Green | Position statement | Hertfordshire and West Essex ICB |
| Stoma - colostomy ileostomy urostomy bag quantities | Stoma | n/a | Patient information | East and North Hertfordshire, South and West Hertfordshire |
| Stoma - colostomy ileostomy urostomy bag quantities | Stoma | Green | Position statement | Hertfordshire and West Essex ICB |
| Stoma - community ostomy service poster | Stoma - DAC | n/a | Prescribing support document | West Essex |
| Stoma - discharge solidifying agent | Stoma | Green | Position statement | Hertfordshire and West Essex ICB |
| Stoma - discharge solidifying agent | Stoma | n/a | Patient information | East and North Hertfordshire, South and West Hertfordshire |
| Stoma - elastic belts | Stoma | n/a | Patient information | East and North Hertfordshire, South and West Hertfordshire |
| Stoma - elastic belts | Stoma | Green | Position statement | Hertfordshire and West Essex ICB |
| Stoma - flange extender retention strip | Stoma | Green | Position statement | Hertfordshire and West Essex ICB |
| Stoma - flange extender retention strip | Stoma | n/a | Patient information | East and North Hertfordshire, South and West Hertfordshire |
| Stoma - gauze swab | Stoma | n/a | Patient information | East and North Hertfordshire, South and West Hertfordshire |
| Stoma - gauze swab | Stoma | Double Red | Position statement | Hertfordshire and West Essex ICB |
| Stoma - ICB Prescribing Guidelines for Stoma Appliances | n/a | Position statement | Hertfordshire and West Essex ICB | |
| Stoma - ilex & Orahesive | Stoma | Green | Position statement | Hertfordshire and West Essex ICB |
| Stoma - leakage notification systems | Stoma | Double Red | Position statement | Hertfordshire and West Essex ICB |
| Stoma - Pastes and Fillers | Stoma | Green | Position statement | Hertfordshire and West Essex ICB |
| Stoma - pastes and fillers | Stoma | n/a | Patient information | East and North Hertfordshire, South and West Hertfordshire |
| Stoma - peristomal skin protective foam applicators and wipes | Stoma | Green | Position statement | Hertfordshire and West Essex ICB |
| Stoma - peristomal skin protective foam applicators wipes | Stoma | n/a | Patient information | East and North Hertfordshire, South and West Hertfordshire |
| Stoma - peristomal skin protective sprays | Stoma | n/a | Patient information | East and North Hertfordshire, South and West Hertfordshire |
| Stoma - powder | Stoma | n/a | Patient information | East and North Hertfordshire, South and West Hertfordshire |
| Stoma - powder | Stoma | Green | Position statement | Hertfordshire and West Essex ICB |
| Stoma - Practical Guide to Stomas for Healthcare Professionals | Stoma | n/a | Prescribing support document | Hertfordshire and West Essex ICB |
| Stoma - Practice appliance contractor letter | Stoma - DAC | n/a | Prescribing support document | Hertfordshire and West Essex ICB |
| Stoma - product samples | Stoma | n/a | Patient information | East and North Hertfordshire, South and West Hertfordshire |
| Stoma - product samples | Stoma | Double Red | Position statement | Hertfordshire and West Essex ICB |
| Stoma - Stoma related surgical procedures | Stoma | n/a | Prescribing support document | Hertfordshire and West Essex ICB |
| Stoma - support garments | Stoma | n/a | Patient information | East and North Hertfordshire, South and West Hertfordshire |
| Stoma - support garments | Stoma | n/a | Position statement | Hertfordshire and West Essex ICB |
| Stoma and continence (appliance and accessories) prescription requests | Stoma - DAC | n/a | Position statement | Hertfordshire and West Essex ICB |
| Stoma Appliance and Accessories Toolkit | Stoma | n/a | Prescribing support document | Hertfordshire and West Essex ICB |
| Stroke | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Strontium | Osteoporosis | Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Sucralfate | Gastrointestinal ulcers | Double Red | Decision document | Hertfordshire and West Essex ICB |
| Sucroferric Oxyhydroxide | Hyperphosphataemia in adult patients with end stage renal failure requiring renal replacement therapy | Amber protocol | Shared care protocol | Hertfordshire and West Essex ICB |
| Suicide Prevention | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Sulfasalazine | Gastroenterology / Rheumatology | Amber protocol | Shared care protocol | Hertfordshire and West Essex ICB |
| Sunscreens | Protection against UV radiation (ACBS) | Green | Decision document | Hertfordshire and West Essex ICB |
| Sunscreens | Protection against UV radiation (ACBS) | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Surgical Removal of Benign Skin Lesions | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Surgical Removal of Benign Skin Lesions Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
| Syncope Care Pathway | n/a | n/a | South and West Hertfordshire | |
| Tacrolimus oral | Transplant rejection (prescribe by brand) NHSE for existing patients | Amber protocol | n/a | Hertfordshire and West Essex ICB |
| Tadalafil | Penile rehabilitation | Red | n/a | Hertfordshire and West Essex ICB |
| Tadalafil | Benign prostatic hyperplasia | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Tamoxifen | Familial breast cancer | Amber initiation | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Tapentadol IR | Pain - acute moderate to severe | Double Red | n/a | Hertfordshire and West Essex ICB |
| Temporomandibular Joint Replacement | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Tenecteplase | Acute ischaemic stroke | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Tennis and Golfers Elbow | n/a | Clinical pathways | South and West Hertfordshire | |
| Tenofovir | AIDS/ HIV Antiretroviral (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Teriflunomide | Relapsing–remitting multiple sclerosis (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Teriparatide | Osteoporosis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Test Syncope Care | n/a | n/a | South and West Hertfordshire | |
| Testosterone | Menopause | Amber initiation | Prescribing guideline | Hertfordshire and West Essex ICB |
| Testosterone | Menopause | n/a | Patient information | Hertfordshire and West Essex ICB |
| Testosterone gel | Menopause | Amber initiation | Decision document | Hertfordshire and West Essex ICB |
| Testosterone transdermal gel (Testavan®, Testogel® or Tostran®) | Male primary hypogonadism in patients aged 18 years and over | Amber initiation | n/a | Hertfordshire and West Essex ICB |
| Testosterone undecanoate (Nebido®) | Male primary hypogonadism in patients aged 18 years and over | Amber initiation | n/a | Hertfordshire and West Essex ICB |
| Thalidomide | Cancer (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Thickeners & thickened ONS guidance Herts Place | Dysphagia | n/a | Prescribing guideline | East and North Hertfordshire, South and West Hertfordshire |
| Thickeners & thickened ONS guidance WE Place | Dysphagia | n/a | Prescribing guideline | West Essex |
| Threadworm | Threadworm | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Throat Symptoms | Adult | n/a | Clinical pathways | South and West Hertfordshire | |
| TIA (Transient Ischemic Attack) | n/a | Clinical pathways | East and North Hertfordshire | |
| Ticagrelor | Preventing atherothrombotic events after myocardial infarction | Amber initiation | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Ticagrelor | Treatment of acute coronary syndromes | Amber initiation | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Tick bites (Lyme disease) | Tick bites (Lyme disease) | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Tildrakizumab | Psoriasis - moderate severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Tioguanine | Leukaemia | Red | n/a | Hertfordshire and West Essex ICB |
| Tirbanibulin | Actinic keratosis | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Tirzepatide | Diabetes type 2 | Amber initiation | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Tirzepatide for obesity | Overweight and Obesity | Green | Decision document | Hertfordshire and West Essex ICB |
| Tixagevimab plus cilgavimab | COVID‑19 | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Tixagevimab plus cilgavimab | COVID-19 | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Tobramycin (TOBI Podhaler) | Cystic fibrosis (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Tocilizmuab | Rheumatoid arthritis - severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Tocilizumab | COVID-19 | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Tofacitinib | Psoriatic arthritis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Tofacitinib | Axial Spondyloarthritis - ankylosing spondylitis | Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Tofacitinib | Rheumatoid arthritis - severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Tofacitinib | Ulcerative colitis - moderate severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Tolvaptan | Kidney disease - autosomal dominant polycystic | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Tolvaptan | Hyponatraemia secondary to SIADH | Red | Decision document | Hertfordshire and West Essex ICB |
| Tongue Tie | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Tonsillectomy for recurrent tonsillitis | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Tonsillectomy for tonsilloliths | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Tonsillitis and Tonsillectomy | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Topiramate | Epilepsy | Amber initiation | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Total Knee Replacement Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
| Tralokinumab | Atopic dermatitis - moderate severe | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Transanal irrigation | Bowel dysfunction | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Transanal irrigation products and quantities | Bowel dysfunction | n/a | Prescribing support document | Hertfordshire and West Essex ICB |
| Transcranial Magnetic Stimulation (TMS and rTMS) | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Travel Vaccines Patient Information Leaflet | Hepatitis B, Rabies, BCG, Meningitis ACWY, Japanese Encephalitis, Yellow fever, Tick-borne encephalitis | n/a | Patient information | Hertfordshire and West Essex ICB |
| Trazodone oral solution to capsules switch Patient letter | Licensed Indications | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Treating your Hay Fever with Over The Counter (OTC) Medicines | Hay fever | n/a | Patient information | Hertfordshire and West Essex ICB |
| Treatment for diabetic hypoglycaemia (hypos) - Position statement | Diabetes – Hypoglycaemia | n/a | Position statement | South and West Hertfordshire |
| Tremor in Primary Care |Initial Assessment | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Tretinoin | Cancer (NHSE) | Red | n/a | Hertfordshire and West Essex ICB |
| Trichomoniasis | Trichomoniasis | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Trientine | Wilsons disease | Red | n/a | Hertfordshire and West Essex ICB |
| Trigger finger release in adults | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Trigger Finger/Thumb | n/a | Clinical pathways | South and West Hertfordshire | |
| Trihexyphenidyl (Benzhexol) | Parkinson's disease | Green | n/a | Hertfordshire and West Essex ICB |
| Trimbow (ICS - beclometasone / LABA - formoterol / LAMA - glycopyrronium) | Asthma | Amber initiation | Decision document | Hertfordshire and West Essex ICB |
| Trimipramine | Depression | Double Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Trimipramine | Depression | n/a | Patient information | Hertfordshire and West Essex ICB |
| Trimipramine - stopping and switching guidance | Depression | Double Red | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Triptorelin as Decapeptyl SR®– Gonadorelin analogue of choice within licensed indications | All licensed indications | Amber initiation | n/a | Hertfordshire and West Essex ICB |
| Ulcerative colitis | Ulcerative colitis - moderate severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Ulipristal | Uterine fibroids | Double Red | Decision document | Hertfordshire and West Essex ICB |
| Unicompartmental Knee Replacement Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
| Upadacitinib | Psoriatic arthritis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Upadacitinib | Atopic dermatitis - moderate severe | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Upadacitinib | Rheumatoid arthritis - severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Upadacitinib | Axial Spondyloarthritis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Upadacitinib | Ulcerative colitis - moderate severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Upadacitinib | Rheumatoid arthritis - moderate | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Upadacitnib | Crohn's disease - moderate to severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Upper GI Cancer - Suspected | ||||
| Urinary incontinence | Adults | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Urinary Incontinence (UI) | n/a | Clinical pathways | East and North Hertfordshire | |
| Urinary Incontinence (UI) Initial Assessment of Women: dipstick urine testing pathway | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Urinary tract infection | Urinary tract infection - lower | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Urinary tract infection | Urinary tract infection - catheter associated | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Urinary tract infection (UTI) | Urinary tract infection | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Urinary Tract Infections (UTI) | Recurrent - adult | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Urinary Tract Infections (UTIs) | n/a | Clinical pathways | Hertfordshire and West Essex ICB, South and West Hertfordshire | |
| Urogynaecology - Female Incontinence and Prolapse | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Urology Cancer - Suspected (excluding Prostate) | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| User guide for Cancelling or Amending eRDs (EMIS and SI) | eRDs | n/a | Prescribing support document | Hertfordshire and West Essex ICB |
| User guide for eRD (EMIS and SI) | eRDs | n/a | Prescribing support document | Hertfordshire and West Essex ICB |
| Ustekinumab | Crohn's disease - moderate to severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Ustekinumab | Psoriasis - moderate severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Ustekinumab | Psoriatic arthritis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Ustekinumab | Ulcerative colitis - moderate severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Vaginosis | Vaginosis - bacterial | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Varenicline | Smoking cessation | Green | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Varicella zoster / chickenpox | Varicella zoster / chickenpox | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Varicose Vein Interventions | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Varicose Veins Management | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Varicose Veins Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
| Vasectomy | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Vasectomy Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
| Vedolizumab | Crohn's disease - moderate to severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Vedolizumab | Ulcerative colitis - moderate severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
| Venlafaxine | Depression, anxiety and panic disorders | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Venlafaxine | Narcolepsy (tertiary centre only) some have agreed amber protocol | Amber initiation | n/a | Hertfordshire and West Essex ICB |
| Venlafaxine oral solution to Tablets Patient Letter | Licensed Indications | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Vericiguat | Heart failure - chronic with reduced ejection fraction | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Vernakalant | Atrial fibrillation | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Vibegron | Overactive bladder syndrome | Green | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Vigabatrin | Epilepsy | Amber initiation | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Virulite Cold Sore Machine | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Vitamin & mineral RAG rating - DEKAs | Paediatric patients with Cystic Fibrosis following tertiary care guidance | Amber initiation | n/a | Hertfordshire and West Essex ICB |
| Vitamin & mineral RAG rating - Iron dextran | Iron deficiency | Red | n/a | Hertfordshire and West Essex ICB |
| Vitamin B compound & compound strong - Position statement | Vitamin insufficiency | n/a | Prescribing guideline | East and North Hertfordshire, South and West Hertfordshire |
| Vitamin B compound & compound strong - Position statement | Vitamin insufficiency | n/a | Prescribing guideline | West Essex |
| Vitamin B12 - Position statement | Vitamin deficiency | n/a | Position statement | Hertfordshire and West Essex ICB |
| Vitamin D | Vitamin deficiency | n/a | Patient information | Hertfordshire and West Essex ICB |
| Vitamin D - Adult and paediatric deficiency & insufficiency guidance | Vitamin deficiency | n/a | Prescribing guideline | West Essex |
| Vitamin D - Adult deficiency & insufficiency guidance | Vitamin deficiency | n/a | Prescribing guideline | East and North Hertfordshire, South and West Hertfordshire |
| Vitamin D - Adult deficiency & insufficiency treatment flowchart | Vitamin deficiency | n/a | Prescribing guideline | East and North Hertfordshire, South and West Hertfordshire |
| Vitamin D - Adult treatment choices | Vitamin deficiency | n/a | Prescribing guideline | East and North Hertfordshire, South and West Hertfordshire |
| Vitamin D - Paediatric deficiency & insufficiency treatment flowchart | Vitamin deficiency | n/a | Prescribing guideline | East and North Hertfordshire, South and West Hertfordshire |
| Vitamin D - Paediatric treatment choices | Vitamin deficiency | n/a | Prescribing guideline | East and North Hertfordshire, South and West Hertfordshire |
| Vitamin D - Position statement | Vitamin insufficiency | n/a | Position statement | Hertfordshire and West Essex ICB |
| Vitamin D & Care Homes - Position statement | Vitamin D insufficiency | n/a | Position statement | Hertfordshire and West Essex ICB |
| Vitamin D guideline | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Vitamin prescribing & bariatric surgery | Vitamin insufficiency | n/a | Prescribing guideline | West Essex |
| Vitamin prescribing & private bariatric surgery | Vitamin insufficiency | n/a | Prescribing guideline | South and West Hertfordshire |
| Vitamin prescribing & private bariatric surgery - Patient information | Vitamin insufficiency | n/a | Patient information | South and West Hertfordshire |
| Voriconazole | Chronic pulmonary aspergillosis and fungal infections (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Vortioxetine | Major depressive episodes | Amber initiation | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Weight Management | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Wet AMD | Wet AMD | Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Zolendronic acid | Osteoporosis | Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Zolmitriptan tablets to orodispersible tablets switch patient letter | Migraine | Green | Patient information | Hertfordshire and West Essex ICB |
| Zonegran caps to generic -switch-letter | Epilepsy | n/a | Patient information | Hertfordshire and West Essex ICB |
| Zonisamide capsules | Epilepsy | Amber initiation | Decision document | Hertfordshire and West Essex ICB |
| Zonisamide oral liquids | Epilepsy | Double Red | Decision document | Hertfordshire and West Essex ICB |